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Abstract 
Purpose: This study investigated the relationship between blood coagulation and 
fibrinolytic potential and physical activity.  Physical activity levels to predict blood 
coagulation and fibrinolytic potential were also examined.  Methods: Twenty-three 
pregnant women, aged 19-34 yrs, had a fasted blood draw between 6 and 10 a.m. 
analyzed for tPA antigen, tPA activity, PAI-1 antigen, and vWF antigen.  Trimester 
specific volume of leisure time physical activity was assessed by the Modifiable Activity 
Questionnaire (MAQ) and converted to METmin/wk.  Based on MAQ results, women 
were grouped as meeting (“active”) or not meeting (“sedentary”) physical activity 
recommendations established by American College of Obstetrics and Gynecology.  
Average daily step count was calculated from 2 week pedometer logs and women were 
categorized as “sedentary” (<5,000 steps/day) or “at least low active” (5,000+ steps/day) 
according to step count.  Results: PAI-1 and tPA antigen were higher and tPA activity 
was lower during the 3
rd
 trimester of pregnancy versus 2
nd
 trimester.  ANCOVA suggests 
gestational age produced an statistically significant model for predicting PAI-1, tPA 
activity, and tPA antigen, but not vWF; average METmin/wk and step count groupings 
did not produce a statistically significant model predicting PAI-1, tPA antigen, tPA 
activity, or vWF but approached statistical significance for tPA antigen (METmin/wk p = 
0.073 and steps/day p = 0.057).  METmin/wk predicted tPA antigen, during pregnancy, 
in a forward stepwise multiple regression.  Linear regressions based on physical activity 
groups resulted in a significant y-intercept difference (p=0.047) for tPA antigen using 
step count classifications.  No significant y-intercept or slope differences were seen in 
vWF in relationship to volume of physical activity using a linear regression model. 
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Conclusion: It appears this is the first study to explore the relationship between 
hemostasis and volume of physical activity during pregnancy, thus providing an impetus 
for further cross sectional and longitudinal studies in this area.  Future research is needed 
because pregnant women are predisposed to a number of thromboembolic complications 
and other health related issues related to hypercoagulation.  Physical activity may 
enhance fibrinolytic and blood coagulation potential during pregnancy, as it can in non-
pregnant adults. 
    
 
 
 
 
Chapter I 
Introduction 
 
The blood coagulation and fibrinolytic cascades involve an intricate series of 
steps and reactions to either enhance the potential to produce fibrin (blood coagulation), 
the key protein in blood clots, or to break down fibrin (fibrinolysis).  Pregnancy is 
defined as a hypercoagulant state, and is characterized by a decrease in fibrinolytic 
activity and an increase in blood coagulation enzymes, resulting in a 2-fold increase in 
coagulation potential in late pregnancy; in healthy women this hypercoagulant state is 
normalized 3-6 weeks postpartum (Choi, 2002; Kruithof, 1987). 
The pattern of increased coagulation potential and reduced fibrinolytic capacity 
during pregnancy may protect pregnant women against the hemostatic challenges of 
placental separation (Bremme, 2003).  However, these changes also present an increased 
risk for thromboembolic complications and hypercoagulability.  The risk for pregnancy 
associated venous thromboembolism (VTE) increases 5.5-6 times compared to 
thromboembolism risk in non-pregnant women of childbearing age (McColl, 1997; 
Macklon, 1996; McColl, 1999; Ishii, 1994).  Pre-eclampsia, characterized by an altered 
state of hemostasis, is the second leading cause of death during pregnancy and 
predisposes women to an increase in coronary heart disease risk later in life (Walter, 
2000; Sattar, 2002).  The majority of miscarriages are associated with combination with 
coagulation issues and are specifically due to placental vessel thrombosis and infarction 
(Bick, 2000).  Additionally, hemostatic disturbances may lead to poor maternal-fetal 
circulation and ultimately restrict fetal growth (Holmes, 2005; Greer, 2002; Greer, 2003) 
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and markers of fibrinolytic inhibition (plasminogen activator inhibitor-1 (PAI-1) and  
tissue-type plasminogen activator (tPA) antigen) have been linked to gestational diabetes 
(Farhan, 2006; Morimitsu, 2007).    
This issue is complicated by the fact that women are becoming pregnant at higher 
starting weights and gaining weight beyond healthy gestational recommendations 
(Huang, 2007; Waller, 2007).  Obesity is known to increase cardiovascular disease risk 
and decrease fibrinolytic potential, increase coagulation potential, and increase 
atherosclerosis (Gaal, 2006) and being overweight/obese is a key risk factor of VTE 
(McColl, 1997; Macklon, 1996; McColl, 1999; Ishii, 1994).  Fat cells synthesize and 
release PAI-1, inhibiting the body’s potential to lyse blood clots.  Obese individuals have 
greater PAI-1, and elevated fibrinogen levels and other coagulation factors versus 
healthy-weighted people (Rauramaa, 1999).  Stewart et al. (2007) reported that obese 
women are in a greater coagulatory state during the first trimester of pregnancy due to 
fibrinolysis inhibition as seen in the PAI-1/PAI-2 ratio.  Although this ratio improved 
among obese women as pregnancy advanced, inability to rebound from this impairment 
could explain elevated maternal risk of pre-eclampsia and hypertension (Stewart, 2007).   
Participation in regular physical activity (PA) may help an individual reduce 
excess body fat and improve overall body composition (Thompson, 2009; HHS, 1996).  
In addition, regular PA is known to enhance the fibrinolytic profile (Regensteiner, 1995; 
Helmrich, 1991; Dempsey, 2004).  Greater leisure time physical activity (LTPA) and 
endurance training have been shown to decrease PAI-1 and fibrinogen while enhancing 
tPA activity (Eliasson, 1996; Boman, 1994).  
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To date, it appears as though there has only been one study investigating the 
relationship between hemostasis and volume of physical activity during pregnancy.  This 
study, by KovalcÃ-kovÃ¡ (1975), is written in Slovak and not available in English, and 
thus little is known about the topic.   
The purpose of the current study was to 1.) study markers of blood coagulation 
and fibrinolysis based on trimester, in pregnant women 2.) determine whether volume of 
physical activity predicts PAI-1, tPA activity, tPA antigen, and vWF in pregnancy and 3.) 
investigate the relationship between volume of physical activity during pregnancy on 
PAI-1, tPA activity, tPA antigen, and vWF.  It was hypothesized that tPA activity would 
be lowest and tPA antigen, PAI-1, and vWF highest in the 3
rd
 trimester and that the extent 
of hypercoagulation during pregnancy would be lower in physically active women, 
versus sedentary women at comparable gestational ages.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter II 
Review of Literature 
Markers of blood coagulation and fibrinolysis are associated with a number of 
pregnancy complications including miscarriage, intrauterine growth restriction, 
gestational diabetes, venous thromboembolism, and pre-eclampsia.  Figure 1 provides an 
overview of the interaction between the fibrinolytic and blood coagulation cascades.  
Tables 1 and 2 are summaries of studies investigating changes in blood coagulation and 
fibrinolytic systems during pregnancy and postpartum.  Specifically, data on tissue 
plasminogen activator (tPA) antigen and activity, and plasminogen activator inhibitor-1 
(PAI-1) (fibrinolytic variables) and the blood coagulation cascade (vonWillebrand factor; 
vWF) are presented.  The research studies presented in the tables demonstrates a general 
trend towards a hypercoagulatory state at the end of pregnancy, which returns to non-
pregnant levels by 4-6 weeks postpartum.  Though values for each of these variables have 
been studied in healthy men and women and the general trends are well established in 
healthy pregnant women, the pattern and extent of change to a hypercoagulatory state has 
not been studied in relation to maternal physical activity level during pregnancy and 
postpartum.  Only one known study, available only in Slovok, has investigated the 
relationship between exercise and hemostasis during pregnancy.  Further information 
regarding the effect of physical activity on fibrinolysis and blood coagulation can be seen 
in tables 3-5.   
 
 
 
 
 
 
 
 
Figure 1. An overview of the fibrinolytic and blood coagulation systems.  Ovals = blood coagulation; rectangles = fibrinolysis; dotted lines = inhibitor.   
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The fibrinolytic and the blood coagulation cascades work in conjunction with 
each other to maintain hemostasis and react to special situations such as pregnancy.  The 
blood coagulation cascade, initiated through either the intrinsic or extrinsic pathway, 
involves a series of steps and reactions leading to the formation of a fibrin clot.  
Specifically, vonWillebrand factor (vWF) is a pro-coagulant protein in the intrinsic 
pathway found in combination with factor VIII in the intrinsic pathway.  The fibrinolytic 
system involves the process of breaking down blood clots, or in other words, breaking 
down fibrin into fibrin degradation products (FDPs).  The process of fibrinolytic potential 
begins with the activation of plasminogen to plasmin by tissue-type plasminogen 
activator (tPA).  tPA activity refers to the amount of free tPA that is able to activate 
plasminogen whereas tPA antigen is the total amount of tPA in the system, free plus 
bound to its inhibitor, plasminogen activator inhibitor-1 (PAI-1).  PAI-1 is the main 
inhibitor of the fibrinolytic system; PAI-1 creates an irreversible bond with tPA and 
inhibits the fibrinolytic process.   
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Table 1. Studies investigating changes in blood coagulation during pregnancy and postpartum. 
Articles Problem/ Question 
Studied 
Participants Procedures Findings 
Coagulation and 
fibrinolysis changes 
in normal pregnancy: 
Increased levels of 
procoagulants and 
reduced levels of 
inhibitors during 
pregnancy induce a 
hypercoagulable 
state, combined with 
a reactive fibrinolysis 
(Cerneca et al., 1997) 
To determine the 
fibrinolytic and blood 
coagulation system 
changes that occur 
during normal 
pregnancy and 
puerperium. 
117 normal, healthy, 
pregnant women and 45 
age-matched, non-
pregnant controls from 
Italy. 
Fasted blood samples were taken at 
weeks 10, 20, 30, and 36 gestation and 2 
days postpartum between 8:30-9:30AM 
for prothrombin time, activated partial 
thromboplastin time, fibrinogen, 
antithrombin III activity, protein S 
activity, protein C activity, tPA antigen, 
and PAI-1. 
There was an increase in procoagulant 
factors during pregnancy.   
Coagulation and 
fibrinolytic 
mechanisms during 
and after normal 
childbirth (Bonnar et 
al., 1970) 
To examine the 
changes in the 
fibrinolytic and 
coagulation systems 
during childbirth. 
15 women with healthy, 
full-term pregnancies 
Blood samples were taken for fibrinogen, 
plasminogen, euglobulin lysis time, 
urokinase sensitivity test, 
fibrin/fibrinogen degradation products, 
platelet count, thrombin clotting time, 
one-stage prothrombin time, factor VIII, 
factor IX, factor V, factor II, partial 
thromboplastin time, kaolin-cephalin 
clotting time, and plastic tube 
recalcification time at 7 increments 
between the end of the second stage of 
labor and 3-5 days after delivery. 
There was a sharp increase in 
coagulation factors during delivery, 
which decreased with placental 
separation.  Normal, non-pregnant 
values of fibrin/fibrinogen degradation 
products were found within an hour of 
delivery. 
Reassessment of von 
Willebrand factor 
(VWF), VWF 
propeptide, factor 
VIII:C and 
plasminogen activator 
inhibitors 1 and 2 
during normal 
pregnancy (Sie et al., 
2003) 
Use various assays to 
reassess vWF and 
factor VIII reference 
values in pregnant 
women.  
 
306 healthy pregnant 
women (about 30 
women for every 3 
week gestational 
period). 
A blood sample was taken and analyzed 
for VWF:Ag, VWF:Ag II, Factor VIII:C, 
PAI-1, and PAI-2. 
VWF antigen and VWF:Ag II increased 
throughout pregnancy. 
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Articles Problem/ Question 
Studied 
Participants Procedures Findings 
Reference intervals 
for plasma levels of 
fibronectin, von 
Willebrand factor, 
free protein S and 
antithrombin during 
third-trimester 
pregnancy 
(Wickstrom et al., 
2004) 
Analyze fibrinolytic 
and blood 
coagulation markers 
during pregnancy and 
establish reference 
values for some of 
the studied variables. 
132 healthy pregnant 
women on an iron 
supplement and at least 
1 previous pregnancy.  
11/132 smoked during 
3
rd
 trimester (9 smoking 
< 10 cigarettes/day, 2 
smoking >10/day).  
97% of women were 
Swedish.  Control 
intervals are based on 
73 non-pregnant 
women and men (50/50 
split; age 20-60). 
 
Blood samples for vWF, antithrombin, 
free protein S, and fibronectin were 
collected at 33, 36, and 39 weeks 
gestation, and 1-3 hours postpartum. 
vWF increased from 33 weeks gestation 
through the postpartum measurement.   
 
Normal pregnancy is associated with an increase in blood coagulation factors, including vonWillebrand factor, contributing to 
a hypercoagulatory state which peaks during labor.   A few researchers have investigated vWF levels at time points throughout 
pregnancy and postpartum (Wickstrom, 2004; Clark, 1998; Sie, 2003).  Values typically begin between 100-150% in the 1
st
 trimester 
and progress linearly to between 200-250% during 3
rd
 trimester.  The data on vWF during postpartum are limited and focus almost 
exclusively on the early postpartum period.  In addition, there is limited evidence available investigating reference values of vWF 
antigen in healthy populations, let alone special populations such as pregnant women (Wickstrom, 2004).  Variance is wide between 
assays, making it difficult to make determinations of whether values have any clinical relevance (Diapharma). 
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Table 2. Studies investigating changes in fibrinolytic potential during pregnancy and postpartum. 
Articles Problem/ Question 
Studied 
Participants Procedures Findings 
Fibrinolysis in 
pregnancy: a study of 
plasminogen activator 
inhibitors (Kruithoff 
et al., 1987) 
To study the actions 
of plasminogen 
activator inhibitors 
throughout pregnancy 
and postpartum. 
90 pregnant women 
with normal pregnancy 
(10 women for each 4-
week gestational 
period), 10 women 
soon after delivery 
(mean time 77 ± 54 
minutes), 10 women 3-
5 days postpartum, and 
10 age-matched non-
pregnant women 
Blood samples were obtained from the 
women to test for tPA, uPA, PAI-1, PAI-
2, total PA, plasminogen, and α2-
antiplasmin. 
PAI-1 levels were greater than non-
pregnant levels (non-significant) with an 
almost linear increase throughout 
pregnancy.  There was about a 50% 
decrease in PAI-1 1-hour post-delivery 
and normal PAI-1 activity was seen 3-5 
days postpartum.  tPA increased during 
pregnancy, plateauing in the last 2 
trimesters, doubling 1 hour postpartum 
and, and remaining slightly elevated 3-5 
days postpartum. 
Coagulation and 
fibrinolysis changes 
in normal pregnancy: 
Increased levels of 
procoagulants and 
reduced levels of 
inhibitors during 
pregnancy induce a 
hypercoagulable 
state, combined with 
a reactive fibrinolysis 
(Cerneca et al., 1997) 
To determine the 
fibrinolytic and blood 
coagulation system 
changes that occur 
during normal 
pregnancy and 
puerperium. 
117 normal, healthy, 
pregnant women and 45 
age-matched, non-
pregnant controls from 
Italy. 
Fasted blood samples were taken at 
weeks 10, 20, 30, and 36 gestation and 2 
days postpartum between 8:30-9:30AM 
for prothrombin time, activated partial 
thromboplastin time, fibrinogen, 
antithrombin III activity, protein S 
activity, protein C activity, tPA antigen, 
and PAI-1. 
There was a decrease in anticoagulants 
during pregnancy.  Fibrinolytic markers 
of tPA and PAI-1 were increased during 
pregnancy and decreased in puerperium.   
Fibrinolysis during 
normal human 
pregnancy: complex 
inter-relationships 
between plasma 
levels of tissue 
plasminogen activator 
and inhibitors and the 
euglobulin clot lysis 
time (Wright et al., 
1988) 
To measure 
fibrinogen, fibrin-
fibrinogen 
degradation products 
(FDP), D-dimer, 
PAI-2, tPA, and 
plasminogen in 
normal pregnancy. 
55 pregnant women and 
16 healthy non-
pregnant controls 
(women 20-35 years) 
from Sweden. 
Cross sectional study where blood 
samples for fibrinogen, FDP, D-dimer, 
PAI-2, tPA, and plasminogen were 
collected at 9-11 weeks (n=12), 22-24 
weeks (n=16), and 36-38 weeks (n=17) 
gestation, within 24 hours postpartum 
(n=5), or between 36-48 hours 
postpartum (n=5). 
Plasminogen was higher than controls 
and increased throughout pregnancy.  
Plasminogen fell postpartum to control 
levels but fibrinogen did not.  tPA 
activity was reduced by the 2
nd
 trimester, 
remaining at that level for the remainder 
of pregnancy.   
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Articles Problem/ Question 
Studied 
Participants Procedures Findings 
Sequential studies on 
components of the 
haemostatic 
mechanism in 
pregnancy with 
particular reference to 
the development of 
pre-eclampsia 
(Condie & Ogston, 
1976) 
To look at the 
development of 
changes in 
hemostasis during 
pregnancy and 
postpartum in an 
effort to determine if 
there are differences 
in women who have 
normal pregnancies 
versus develop 
preeclampsia. 
60 women (age range 
18-25 years) in their 
first pregnancy and 10 
never-pregnant controls 
(< 25 years) 
Blood samples for fibrinolytic activity, 
fibrinolytic capacity, plasma 
plasminogen, plasma fibrinogen, serum 
fibrinogen/fibrin related antigen, urinary 
FR-antigen, and serum α1-antitrypsin and 
α2-macroglobulin  were taken at 12, 20, 
30, and 38 weeks gestation, after 
placental delivery (30 minutes), 24, 48, 
96, 144 hours postpartum and 6 weeks 
postpartum. 
Plasminogen was higher during 
pregnancy than in controls.   
Reassessment of von 
Willebrand factor 
(VWF), VWF 
propeptide, factor 
VIII:C and 
plasminogen activator 
inhibitors 1 and 2 
during normal 
pregnancy (Sie et al., 
2003) 
Use various assays to 
reassess vWF and 
factor VIII reference 
values in pregnant 
women.  
 
 
306 healthy pregnant 
women (about 30 
women for every 3 
week gestational 
period). 
A blood sample was taken and analyzed 
for VWF:Ag, VWF:Ag II, Factor VIII:C, 
PAI-1, and PAI-2. 
PAI-1 increased throughout pregnancy, 
until the very end, when it fell. 
APC resistance and 
other haemostatic 
variables during 
pregnancy and 
puerperium 
(Kjellberg et al., 
1999) 
To investigate the 
relationship between 
markers of 
hemostasis and 
change in activated 
protein C ratio during 
pregnancy, to 
determine blood 
coagulation reference 
values, and to 
confirm normality in 
hemostatic balance 
during pregnancy. 
27 nulliparous, 19 
primiparous, 2 
multiparous women 
(mean 29 years) 
without any bleeding 
disorders. 
Prospective, longitudinal study. Blood 
samples at 10-15, 23-25, 32-34, and 38-
40 weeks gestation, within 1 week and 
during the 8
th
 week postpartum for Hb, 
hct, platelet count, tPA, APC ratio, factor 
VIII, fibrinogen, protein C, free protein S, 
prothrombin 1+2, fibrin, D-dimer, PAI-1, 
and PAI-2. 
PAI-1 increase significantly with 
pregnancy progression.  PAI-1 decreased 
by the time women left the hospital 
following delivery.  tPA activity 
significantly decreased with pregnancy 
progression.   
1
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Articles Problem/ Question 
Studied 
Participants Procedures Findings 
Enhanced thrombin 
generation and 
fibrinolytic activity in 
normal pregnancy 
and the puerperium 
(Bremme et al., 1992) 
To study fibrinolytic 
markers and 
coagulant inhibitory 
indices throughout 
pregnancy. 
26 pregnant women 
(mean age 28, age 
range 20-38; 12 in their 
1st pregnancy, 9 in their 
2
nd
, and 5 who had have 
multiple previous 
pregnancies). 
Morning blood draws following a 10-hour 
fast were taken at weeks 12-15, 24, and 
35 gestation, immediately following 
placental delivery, and 5 week 
postpartum for platelet count, fibrinogen, 
prothrombin complex, antithrombin, 
protein C, protein S (total and free), 
soluble fibrin, TAT, D-dimers, PAI-1, 
PAI-2, and cardiolipin antibodies 
positive. 
PAI-1 increased during pregnancy, 
reaching a level of 90 AU/mL at 35 
weeks gestation. 
Tissue plasminogen 
activator levels 
change with plasma 
fibrinogen 
concentrations during 
pregnancy (Choi & 
Pai, 2002) 
To study the 
fibrinolytic and blood 
coagulation systems 
during normal 
pregnancy 
436 women were 
studied (1
st
 trimester: 
107, 2
nd
 trimester: 65, 
3
rd
 trimester: 123, 
postpartum: 109, non-
pregnant: 32) 
Blood samples were analyzed for markers 
of coagulation (VII, VIII, IX, X, XI, XII, 
fibrinogen), prothrombin time, activated 
partial thromboplastin time, antithrombin 
III, tPA, PAI-1, D-dimer, and protein S. 
Levels of tPA antigen, and plasma 
fibrinogen levels were greater in the 3
rd
 
trimester than the 1
st
 trimester, and tPA 
antigen and plasma fibrinogen had 
decreased, in comparison to peak 
pregnancy levels, 5-8 weeks postpartum. 
tPA activity in 
peripheral blood 
obtained from 
pregnant women 
(Ishii et al., 1994) 
Use a new method to 
clarify changes in 
fibrinolysis potential 
that occur throughout 
pregnancy. 
Pregnant women 
(unspecified number). 
Blood samples were taken in women 
between 10 and 11am for tPA activity, 
tPA antigen, and PAI activity.  Study 
layout is unspecified (longitudinal vs. 
cross sectional) but control blood samples 
as well as samples from 8, 12, 16, 20, 24, 
28, 32, 36, 40 weeks gestation, and within 
2 days puerperium were taken. 
tPA activity dramatically decreased 
during pregnancy and increased to 
almost non-pregnant levels by 48 hours 
postpartum.  tPA antigen gradually 
increased during pregnancy and 
decreased to almost non-pregnant levels 
by 48 hours postpartum.  PAI-1 
increased during pregnancy and 
decreased to non-pregnant levels by 48 
hours postpartum. 
 
Source of increased 
plasminogen 
activators during 
pregnancy and 
puerperium (Shimada 
et al., 1989) 
 
To examine uPA and 
tPA antigen levels 
during pregnancy, 
delivery, and 
postpartum. 
43 non-pregnant 
women of child-bearing 
age, 73 healthy 
pregnant women, and 
54 postpartum women 
Cross sectional study with women 
grouped by trimester, stage of delivery, or 
postpartum.  3 women were studied at 
multiple time points.   
There were no significant changes in 
tPA from 1
st
 to 2
nd
 trimester, with both 
increasing significantly during the 3
rd
 
trimester.  tPA antigen continued to rise 
immediately after childbirth before 
dropping. 1
1
 
 
 
 
 
Articles Problem/ Question 
Studied 
Participants Procedures Findings 
Fibrinolysis changes 
in normal pregnancy 
(Bellart et al., 1997) 
To study changes in 
tPA, PAI-1, PAI-2, 
and D-dimer during 
pregnancy, delivery, 
and 3 days 
postpartum. 
60 pregnant women 
with healthy pregnancy 
(mean age 29 years). 
In 60 women, blood samples for tPA, 
PAI-1, PAI-2, and D-dimer were taken 
during each trimester of pregnancy.  20 of 
these women also had blood samples 
taken during delivery and 3 days 
postpartum. 
tPA increased during pregnancy, 
exceeding the normal non-pregnant 
range after 1
st
 trimester and reaching 
peak levels at delivery, returning to 
normal 3 days postpartum.  PAI-1, 
though remaining within normal non-
pregnant range, were significantly higher 
2
nd
 and 3
rd
 trimester and during delivery.   
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Healthy pregnancy is associated with a decrease in fibrinolytic enzymes, 
including tPA activity, and an increase in markers of fibrinolytic inhibition, including 
PAI-1 and tPA antigen.  These changes help contribute to a hypercoagulant state which 
peaks during labor and return to non-pregnant levels post-partum. 
PAI-1 activity values begin between 7.4 and 10.25AU/mL in first trimester, 
progressing to between 11.26 and 14.9 AU/mL in 2
nd
 trimester, and then vary greatly in 
3
rd
 trimester, with values of 22.41 and 37.8 AU/mL  Despite the differences in the 3
rd
 
trimester, there is an increase in PAI-1 in the 3
rd
 trimester compared to the 2
nd
 trimester.  
In contrast, studies investigating PAI-1 levels in healthy non-pregnant women suggest 
wide variability in average values, but all normal values do fall below 15 AU/mL 
(Holmes, 2005; Kruithoff, 1987; Cerneca, 1997; Ranby, 1990; Eliasson, 1993).  Kruithof 
et al. (1987) found an almost linear increase in PAI-1 throughout pregnancy. Cerneca et 
al. (1997) studied 117 pregnant women from Italy and took blood samples between 8:30-
9:30am.  Stirling et al. (1984) studied 72 women of various races (59 whites, 6 Asians, 4 
blacks, and 3 Chinese) with no time listed for when the blood draws occurred.  It is 
possible that differences in these 2 studies during the 3
rd
 trimester are consequence of 
diurnal variation in PAI-1 activity or could be an effect of race; obtaining blood samples 
between 7 and 10 a.m. minimizes diurnal variation. Postpartum values are not all shown 
due to vague time points but do conform to a general trend in a rapidly decreasing PAI-1 
activity level following delivery, returning to non-pregnant levels by 3-5 days 
postpartum.   
Healthy, non-pregnant values for tPA activity range between 0.1-1.5 IU/mL 
(Kjellberg, 1999; Wimer, 1985; Eliasson, 1993). Kjellberg et al. (1999), investigated tPA 
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activity levels during pregnancy and postpartum, finding an almost linear decrease from 
1
st
 to 3
rd
 trimester,  
returning to pre-pregnancy levels postpartum.  Data is more limited here as many 
studies look at plasminogen, but not specifically tissue-type plasminogen activator 
activity.   
A number of studies investigated tPA antigen levels at time points throughout 
pregnancy and postpartum (Bellart, 1997; Kruithof, 1987; Shimada, 1989; Cerneca, 1997; 
Choi, 2002).  The majority of the studies listed begin with values between 2.5-4.5 ng/mL 
for the 1
st
 semester with an increase to between 6-8 ng/mL by the end of 3
rd
 trimester.  
Postpartum values show a marked decrease in tPA antigen initially with values back 
down to non-pregnant or 1
st
 trimester levels by 6 weeks postpartum. Studies investigating 
non-pregnant levels of tPA antigen report mixed results.  Studies analyzing healthy, non-
pregnant tPA antigen levels using ELISA kits show a small range in findings.  Choi and 
Pai (2002), Eliasson et al. (1993), and the Imubind® tPA ELISA Kit (American 
Diagnostica) studied 32 women (mean age 26.7), 72 women age 25-34, and 95 healthy 
women, respectively, finding a mean tPA antigen level between 3.9-4.0 ng/mL.  A study 
looking at non-pregnant women in Italy found much higher tPA antigen levels (7.1±5.5 
ng/mL) and a study of 10 healthy women found lower levels (2.2±0.8 ng/mL; Cerneca, 
1997).  An earlier study using an immunoradiometric assay found lower values for tPA 
antigen in healthy non-pregnant women (2.2±0.8 ng/mL; Kruithoff, 1987).  
 
 
 
 
Table 3. Cohort studies investigating the acute effects of exercise on blood coagulation and fibrinolytic markers, independent of pregnancy. 
Articles Problem/ Question 
Studied 
Participants Procedures Findings 
Activation and 
disturbance of blood 
hemostasis following 
strenuous physical 
exercise (Lin et al., 
1998) 
Investigate markers 
of fibrinolysis and 
blood coagulation 
immediately and 24 
hours post-exercise 
using modern 
analytical techniques. 
11 moderately active 
participants (mean 24.2 
years) 
Cycle ergometer test.  5 min WU at 
120W, 35 min at 70% VO2max. Blood was 
taken at baseline, 2, 6, and 24 hours post-
exercise for tPA activity and antigen, 
PAI-1 activity, total fibrin/fibrinogen 
degradation products. 
tPA activity and antigen significantly 
increased at end-exercise versus rest, 
returning to baseline by the 2 hr post 
blood draw.  PAI-1 activity was 
significantly decreased during exercise 
and returned to resting levels 2 hours 
post exercise.   
The effect of different 
exercise intensities on 
the fibrinolytic 
system (Molz et al., 
1993) 
To investigate the 
effect of exercise 
intensity on 
fibrinolytic markers 
10 untrained women 
and 10 untrained men 
(22-34 years) 
Cycle ergometer test (begin at 50W and 
increase 10W/min until HR of 120 bpm.  
Hold that intensity for 30 minutes, then 
increase 25W every 2 min until 
exhaustion or HR 180-190 bpm.  Before 
and after the exercise test blood samples 
were taken for Hb, tPA activity and 
antigen, D-dimer, PT, APPT. 
tPA activity was increased after 
moderate and maximal exercise, 
dropping by 30 min post-exercise.  A 
greater increase was seen immediately 
following the maximal exercise. 
Blood fibrinolytic 
activity in man 
(Rosing et al., 1970) 
To determine the 
relationship between 
magnitude of 
fibrinolytic response 
and intensity of 
exercise as well as to 
look at diurnal 
variations in 
fibrinolytic markers 
2 healthy women and 
12 healthy men (19-30 
years) 
Maximal exercise = running speed that 
exhausted the person in 5 minutes.  40% 
and 70% of max exercise were 
investigated. Blood samples were taken 
every 2-3 hours over a 24 hour span and 
exercise blood measures were taken 
before exercise and every 5 minutes 
during exercise for fibrinogen, 
fibrinolytic activity, plasminogen. 
Fibrinolytic activity increased from 
8AM to 3PM.  Fibrinolytic activity 
increased during each exercise bout and 
quickly returned to normal following 
exercise.   
Acute dynamic 
exercise increases 
fibrinolytic activity 
(Rankinen et al., 
1995) 
To compare how tPA 
and PAI are effected 
by submaximal and 
max exercise (acute). 
9 healthy men (23-37 
years) 
VO2max, anaerobic and aerobic threshold 
tests on a cycle ergometer.  Blood taken 
at rest 3-4 hours after a standard 
breakfast, IPE, and 24 hours post-exercise 
for plasma fibrinogen, tPA activity, PAI-
1. 
tPA activity increased IPE and returned 
to baseline at 24 h post-exercise in all 3 
exercise conditions, with a greater 
increase seen during the VO2max and 
anaerobic threshold tests.  PAI-1 activity 
decreased IPE during the VO2max and 
anaerobic threshold tests but no in the 
aerobic threshold test. PAI-1 returned to 
baseline 24 h post-exercise.  
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Articles Problem/ Question 
Studied 
Participants Procedures Findings 
Effects of exercise 
intensity, duration, 
and time of day on 
fibrinolytic activity in 
physically active men 
(Szymanski & Pate, 
1994) 
To determine the 
effect of time of day 
on fibrinolytic 
responses to 
sumbmaximal 
exercise and to 
determine how 
duration, intensity, 
and caloric 
expenditure during 
submaximal exercise 
are related to 
fibrinolytic 
responses. 
12 healthy men (28-43 
years) who had jogged 
3-5 d/wk for 30 min 
over the past 3 months. 
Treadmill VO2max, 30 minute morning 
and afternoon sessions at 50% VO2max and 
80% VO2max (4 submax trials). Blood 
samples were taken before, during, and 
IPE for Hb, hct, tPA activity, PAI-1. 
tPA activity increased during all exercise 
sessions but was insignificant during the 
50% morning session and greater 
increases were found in the 80% 
sessions.  PAI-1 response was not 
different due to intensity but did show 
significant decreases in PAI-1 activity in 
all but the 50% afternoon session. 
Balanced activation 
of coagulation and 
fibrinolysis after a 2-
h triathlon (Bartsch et 
al., 1995) 
To investigate 
whether fibrin, 
thrombin, and 
plasmin in vivo are 
effected by strenuous, 
prolonged exercise. 
10 men (age 19-38) 
participating in a short 
triathlon. 
Triathlon (1.7 km swim, 40 km bike, 10 
km run).  Blood was taken 1 day pre-race, 
IPE, and 2, 8, and 21 hr post-triathlon for 
beta-thromboglobulin, fbrinopeptide A, 
APTT, ELT, F1+2, TAT, antithrombin 
III, plasmingen, α-2- antiplasmin, tPA, 
PAI-1, FbDP. 
 
tPA antigen was highest IPE, returning 
to baseline 21 hrs post-exercise.  PAI-1 
antigen was highest 2 hrs post-exercise 
and returned to baseline by 8 hrs post-
exercise. 
Changes in the 
fibrinolytic system 
associated with 
physical conditioning 
(Paz, 1992) 
To determine the 
fibrinolytic response 
to maximal exercise. 
23 healthy men (20-24 
years); 10 who do not 
engage in any sport, 12 
middle distance runners 
running >80 km/wk 
VO2max test (Bruce protocol). Blood was 
studied for plasminogen, α2-antiplasmin, 
antithrombin III, fibrinogen, fibrinogen 
degradation products, tPA and PAI 
activity and tPA and PAI antigen. 
Runners had increased tPA activity and 
decreased PAI activity at rest. Post-
exercise, tPA activity and antigen were 
increased in both groups; tPA antigen 
increased to a greater extent in runners.   
Fibrinolytic and 
hemostatic changes 
during and after 
maximal exercise in 
males (Davis et al., 
1976) 
To study hemostatic 
and fibrinolytic 
changes in 10 healthy 
males in response to 
a maximal exercise 
test on a bicycle 
ergometer. 
10 healthy men (22-27 
years) 
VO2max test (bicycle ergometer). Blood 
was taken for fibrinogen, factor VIII, 
cholesterol, triglycerides, hematocrit, 
white blood cell count, fibrinolytic 
activity. 
Little change occurred before 50-60% 
VO2max/ 70-80% HRmax.  The greatest 
fibrinolytic response was evident at 
HRmax.  Fibrinolytic activity decreased 
in an almost linear fashion within the 1
st
 
10 minutes post-exercise.  Factor VIII 
rose during exercise and peaked 5-10 
minutes post-exercise. 
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Articles Problem/ Question 
Studied 
Participants Procedures Findings 
Evaluation of clotting 
and fibrinolytic 
activation after 
protracted physical 
exercise (Prisco et al., 
1998) 
To examine the 
duration and extent of 
fibrinolytic and blood 
clotting activation 
after a marathon. 
12 healthy male 
marathon runners (25-
47 years) 
International Marathon of Florence 
(Italy). Blood was taken the day prior to 
competition, IPE, 1 day post-marathon, 2 
days post-marathon for fibrinogen, F1+2, 
TAT, ELT, tPA antigen, PAI-1 activity, 
PAI-1 antigen, D-dimer, FgDP. 
PAI-1 antigen, tPA antigen, D-dimer, 
and FgDP were increased IPE.  There 
was an insignificant decrease in PAI-1 
activity IPE.  24 hours post race 
measures were still altered, they returned 
to baseline by 48 hours post-marathon. 
Increases in factor 
VIII complex and 
fibrinolytic activity 
are dependent on 
exercise intensity 
(Andrew et al., 1986) 
To determine the 
relationship between 
3 different types of 
exercise on 
fibrinolytic markers 
and the factor VIII 
complex. 
5 men (25-44 years) 
who are moderately 
active 
VO2max (cycle ergometer), low-intensity 
steady state exercise, 30 sec max effort 
test on a cycle ergometer. Blood samples 
taken prior to each exercise bout, in the 
last 30 seconds of each stage of the max 
test, 10 and 60 minutes post-exercise, for 
plasminogen, FPA, WBC, Hb, APTT, PT, 
fibrinogen, WBCLT, factors II, V, VIII 
complex, XII.  Factor VIII:vWF 
measured using human platelets and 
ristocetin in formaldehyde. 
It wasn’t until 80% max that changes in 
factor VIII complex were seen during 
the max test.  There were no major 
changes in factor VIII complex 
following steady state.   increased 
following exercise and peaking at 10 
minutes post-exercise following the 30 
sec exercise.   
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The studies presented in table 3 include investigations that were designed to 
determine the effect of an acute bout of exercise on markers of fibrinolysis and blood 
coagulation.  The majority of these studies focused on healthy individuals (primarily 
males) in their 20’s and 30’s, many of which were physically active.  Though there is 
more limited data specifically looking at the effect of acute exercise on fibrinolytic and 
blood coagulation markers in women, there appear to be no substantial differences in the 
pattern of effect of these markers in men and premenopausal women (Schuit, 1997; 
Kulaputana, 2005; Eliasson, 1993). The intensity, duration and mode of the acute bout of 
exercise vary greatly among the investigations with some including an anaerobic 
threshold test while others included the measurement of VO2max and some included 
measurements following an hour of exercise at various intensities and modes (triathlons, 
marathons, and 100 km race and utilizing walking, running, cycling, and swimming). 
In response to acute exercise, vWF specifically has not been studied to a great 
extent, but factor VIII, which in complex includes vWF, has been shown to rise during 
exercise and peak 5-10 minutes post-exercise, which changes evident in exercise above 
80% VO2max (Davis, 1976; Andrew, 1986).  Overall, it appears that blood coagulation as 
a whole increases due to an acute bout of exercise, peaking and remaining elevated for a 
couple hours following exercise. 
The pattern of fibrinolytic response to an acute exercise bout is backed by strong 
evidence; PAI-1 activity decreases while tPA activity and antigen increase.  A greater 
increase in tPA antigen has been found in runners versus sedentary individuals (Paz, 
1992).  A greater increase in tPA has also been found with increased intensity, especially 
at max (Molz, 1993).  PAI-1 activity, tPA activity, and tPA antigen all quickly return to 
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baseline following exercise.  This, in conjunction with the increased blood coagulability 
following an acute bout of exercise, results in a couple hours of increased coagulatory 
potential following exercise.  
 
 
 
 
Table 4. Cross-sectional and prospective studies investigating the chronic effects of exercise on blood coagulation and fibrinolysis, independent of pregnancy, in 
cross-sectional studies. 
Articles Problem/ Question 
Studied 
Participants Procedures Findings 
Physical activity and 
hemostatic and 
inflammatory 
variables in elderly 
men (Wannamethee 
et al., 2002) 
To examine the 
relationship between 
inflammation, 
viscosity, hemostatic 
variables, and 
exercise. 
3954 men 60-79 years, 
30% on aspirin 
Questionnaire assessing usual PA under 
regular cycling/walking, recreational, and 
sporting (vigorous) activity using 
frequency and type.  Men grouped into 6 
categories (1. Inactive, 2. Occasional, 3. 
Light, 4. Moderate, 5. Moderately 
vigorous, 6. Vigorous. Blood was tested 
for clottable fibrinogen, tPA antigen and 
vWF, D-dimer, CRP, factors VII, VIII, 
IX, APC resistance, and aPTT.   
PA and many hemostatic and 
inflammatory markers are inversely 
associated, including vWF and tPA 
antigen and remain after adjusting for 
BMI, pre-existing CVD, age, etc. ~40% 
reduction in high fibrinogen and ~30% 
reduction in high tPA antigen levels was 
seen with moderate PA.  Men who 
remained active and became active 
showed lower hemostatic variables than 
those currently inactive. 
Physical activity 
status and adverse 
age-related 
differences in 
coagulation and 
fibrinolytic factors in 
women (DeSouza et 
al., 1998) 
To determine if there 
are age related 
differences in 
fibrinolytic and blood 
coagulation factors in 
women 
51 healthy women in 4 
groups (11 pre-
menopausal sedentary, 
13 pre-menopausal 
active, 14 post-
menopausal sedentary, 
13 post-menopausal 
active.  The active 
women are from 
running clubs. 
 
 
VO2max. Blood was taken for fibrinogen; 
tPA antigen, PAI-1 activity and antigen, 
and D-dimer. 
Post-sedentary women had higher PAI-1 
activity and antigen and tPA antigen, 
and lower tPA activity than pre-
sedentary women.  tPA antigen, PAI-1 
activity and antigen were lower and tPA 
activity was high in post-active women 
versus post-sedentary women but not in 
relation to pre-active women. 
Regular leisure time 
physical activity 
predicts high activity 
of tissue plasminogen 
activator: The 
northern Sweden 
MONICA study 
(Eliasson et al., 1996) 
To investigate the 
relationship between 
physical activity and 
fibrinolytic variables. 
250 women and 250 
men in each age group 
(25-34, 35-44, 45-54, 
55-64 years) from 
Sweden 
Self-report LTPA (no/light PA, light PA, 
moderate PA, moderate/strenuous PA). 
Blood was taken for tPA activity and 
mass,  PAI-1 activity, triglycerides, and 
insulin. 
tPA activity was higher as physical 
activity increased but was only 
significant in men.  tPA mass decreased 
significantly with increased activity in a 
linear fashion. PAI-1 activity decreased 
as PA increased. 
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Articles Problem/ Question 
Studied 
Participants Procedures Findings 
Lifestyle and 
hemostatic risk 
factors for ischemic 
heart disease: The 
Caerphilly study 
(Yarnell et al., 2000) 
 
To examine the effect 
of lifestyle factors on 
hemostatic variables. 
2398 men (45-59 years) Minnesota Leisure Time Activity 
questionnaire.  Blood was taken for tPA, 
PAI-1 activity, clottable fibrinogen, D-
dimer, viscosity, and white cell count. 
vWF and D-dimer and LTPA were 
significant related, as LTPA increased, 
vWF and D-dimer decreased.   
 
A number of studies have used physical activity questionnaires to determine the relationship between physical activity and 
markers of coagulation (Lakka, 1993; Abramson, 2002; Wanameethee, 2002; Yarnell, 2000; Panagiotakos, 2005; Eliasson, 1996).  
Wanameethee et al. (2002) and Yarnell et al. (2000) found an inverse relationship between activity level and vWF.  As physical 
activity level increases in cross-sectional studies, fibrinolysis potential is improved.  This enhancement can be seen by an increase in 
tPA activity and a decrease in tPA antigen and PAI-1 (Eliasson, 1996; Wannamethee, 2002). 
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Table 5. Intervention studies investigating the chronic effects of exercise on blood coagulation and fibrinolysis, independent of pregnancy, in intervention 
studies. 
Articles Problem/ Question 
Studied 
Participants Procedures Findings 
Effects of high and 
low intensity aerobic 
conditioning 
programs on blood 
fibrinolysis and lipid 
profile (El-Sayed, 
1996) 
To examine the effect 
of low and high 
intensity exercise 
interventions on 
fibrinolytic and lipid 
markers. 
8 untrained females and 
10 untrained males 
(mean age 27.2 years) 
Participants were randomly assigned to 
either a low intensity (30% VO2max) or 
high intensity (80% VO2max) group.  
Exercise involved 20 min, 3x/wk for 12 
weeks of cycling (Monark bicycle 
ergometer), plus a 5 minute warm up and 
cool down. Blood samples were tested for 
cholesterol, triglycerides, tPA activity and 
antigen, PAI-1 activity and antigen. 
PAI-1 activity was significantly 
decreased from baseline in the high 
intensity group.  
Effect of strenuous 
exercise on 
fibrinogen and 
fibrinolysis in healthy 
elderly men and 
women (Schuit et al., 
1997) 
To determine the 
effect of a 6 month 
exercise intervention 
on tPA activity, PAI-
1, and fibrinogen 
among the Dutch 
116 Dutch women and 
113 Dutch men (60-80 
years) with blood 
markers in 94 women 
and 88 men 
Randomly assigned to either an exercise 
(bicycle) group (48 women, 48 men) or a 
control group (46 women, 40 men).  The 
exercise group received a home exercise 
bike and trained 30 min/d, 4 d/wk for 6 
months (50% HRmax progressing to 70% 
as intervention advanced). Blood was 
analyzed for fibrinogen, PAI-1 antigen, 
tPA, CRP, HDL, and insulin. 
No differences between men and women 
for fibrinogen, PAI-1 antigen, or tPA 
activity were found.  tPA activity 
increased to a significantly higher 
amount and PAI-1 antigen modestly 
decreased in the exercise group, with the 
largest changes seen in previously 
inactive individuals.  Fibrinogen was 
also increased to a greater extent in the 
exercise group. 
 
Effects of endurance 
training and seasonal 
fluctuation on 
coagulation and 
fibrinolysis in young 
sedentary men (van 
den Burg et al., 1997) 
To study the effect of 
moderate intensity 
physical training on 
fibrinolysis and blood 
coagulation. 
40 sedentary men (20-
30 years) randomly 
assigned to either 
training or control 
groups (20 in each) 
Cycle ergometer VO2max, cycle ergometer 
4-part test (gradual increase to 70% 
VO2max, 15 min steady state, four 1-
minute increases in intensity to VO2max, 
10 minute active recovery.  12 week 
intervention supervised training 2x/wk 
working for 1 hour at 60-70% VO2max. 
Blood was taken at baseline, after 6 wks, 
and after 12 weeks for factors VII, VIII, 
IX, XII, fibrinogen, APTT, prothrombin 
time, tPA antigen and activity, PAI-1 
activity, and uPA antigen. 
Factors VII, IX, XII, prothrombin time, 
and fibrinogen did not change because 
of the intervention.  tPA antigen, PAI-1 
activity and antigen decreased in the 
training group and increased in the 
control group post-intervention 
(significant interaction effect). 
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Articles Problem/ Question 
Studied 
Participants Procedures Findings 
Blood coagulability 
and fibrinolytic 
activity before and 
after physical training 
during the recovery 
phase of acute 
myocardial infarction 
(Suzuki et al., 2002) 
To look at the effect 
of exercise during 
recovery from MI on 
markers of blood 
coagulation and 
fibrinolysis. 
11 women and 75 men 
(35-82 years) assigned 
to either exercise group 
(56) or control (30) 
depending on if their 
physician prescribed 
exercise. 
Exercise began 29±3 days post-MI and 
lasted 31±5 days with 6 d/wk of two 40-
minutes sessions (morning and afternoon) 
with the majority of time spent walking 
(<120 bpm). Blood samples were taken 
for PT, APTT, α1AT, α2MG, fibrinogen, 
ATIII, plasminogen, α2PI, factors VIII:C, 
vWF:Ag, hct, platelet count, ELT.  A 
subset group (C) was also tested for tPA 
activity and antigen, PAI-1, TAT, VII:C, 
P-C:Ag, PIC. 
vWF:Ag, VIII:C, ATIII all decreased in 
the training group while remaining 
unchanged in the control group.  Subset 
C found a decrease in tPA antigen and 
PAI-1, in addition to TAT, PIC, P-C:Ag, 
and VII:C after training and no change 
in tPA activity. 
Effects of a 
moderate-intensity 
aerobic program on 
blood viscosity, 
platelet aggregation 
and fibrinolytic 
balance in young and 
middle-aged 
sedentary subjects 
(Coppola et al., 2004) 
To determine if a 
moderate aerobic 
exercise program 
improves fibrinolytic 
balance in sedentary 
young and middle-
aged people. 
15 university students 
(5 female; mean age 
27.9 ± 3 yrs) and 15 
professors (4 female) 
3x/wk for 12 wks of aerobic activity (10 
min WU, 40 min walk or run on 
treadmill).  Blood samples were tested for 
hct, Hb, blood cell count, fibrinogen, tPA 
antigen and PAI-1 antigen, and platelet 
aggregation. 
tPA antigen lower in young vs. middle-
aged participants.  No changes in tPA 
antigen due to the intervention.  PAI-1 
antigen was significantly increased in 
the middle-aged but not the young 
participants. 
 
 
 Intervention studies looking at the effect of chronic exercise on coagulation and fibrinolysis, reviewed here, range from 1-6 
months in length, primarily utilized aerobic modes of activity (walking, running, cycling, Canadian Air force training), and involved a 
healthy, active individuals, as well to sedentary individuals and post MI patients.    A study by Suzuki et al. (1992), found a decrease 
in vWF following the 1 month intervention in post MI patients. 
 
2
3
 
 
 
 
 
Summary 
The findings of the individual studies above (Suzuki, 1992; van den Burg, 1997; 
Schuit, 1997) are consistent with a review by Womack et al. (2003) regarding fibrinolytic 
variables.  As an adaptation to exercise, PAI-1 activity and tPA antigen decrease and tPA 
activity increases, resulting in an enhanced fibrinolytic potential.  El-Sayed (1996) found 
that PAI-1 decreased following a 12 week cycling intervention in a high intensity 
exercise group (80% VO2max) but not in a low intensity group (30% VO2max), suggesting 
that intensity of exercise may play a greater role in determining expected fibrinolytic 
adaptations to exercise. 
 The normal progression of fibrinolytic and blood coagulation variables in low risk 
pregnancies has been well established.  Markers of blood coagulation (e.g. vWF) and 
fibrinolytic inhibition (e.g. PAI-1, tPA antigen) increase as pregnancy advances and 
fibrinolytic markers (e.g. tPA antigen) decrease, creating a hypercoagulant state which 
peaks at the end of pregnancy and returns to non-pregnant levels by 4-6 weeks 
postpartum.  The changes in blood coagulation and fibrinolytic potential, seen in tables 1 
and 2, provide the physiological benefit of protecting the mother against bleeding out in 
excess during placental separation.  However, these changes also predispose the woman 
to a number of thromboembolic complications and other health related issues related to 
hypercoagulation including miscarriage, pre-eclampsia, venous thromboembolism, 
intrauterine growth restriction, and diabetes (Greer, 2003).   
 The response of fibrinolytic markers to an acute bout of exercise is well 
established, whereas findings are inconsistent in regards to blood coagulant markers.  
During an acute bout of exercise, PAI-1 activity decreases while tPA activity and antigen 
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increase, returning quickly to baseline following exercise.  Blood coagulation as a whole 
increases due to an acute bout of exercise, peaking and remaining elevated for a couple 
hours following exercise.  Together, this results in a couple hours of increased 
coagulatory potential following exercise.   
In contrast to acute bouts of exercise, fibrinolytic potential is enhanced as a result 
of chronic exercise, as seen by a decrease in PAI-1 activity and tPA antigen and an 
increase in tPA activity (Eliasson, 1996; Wannamethee, 2002).  As with an acute bout of 
exercise, research involving vWF adaptation to chronic exercise is limited.   
The progression of fibrinolytic and blood coagulation markers in low risk 
pregnancy is well established.  In addition, it is well understood that chronic exercise 
enhances an individual’s fibrinolytic profile.  Data has been collected regarding exercise 
in healthy sedentary and active non-pregnant populations, men and women, various 
disease populations (primarily CVD), but only one known study, not available in English, 
has investigated the fibrinolytic profile in relationship to exercise during pregnancy 
(KovalcÃ¬kovÃ¡, 1975).  The purpose of the current study was to (1) study differences 
in markers of blood coagulation and fibrinolysis based on trimester, in this cohort of 
women and (2) investigate the relationship between volume of physical activity, during 
pregnancy and postpartum, on blood coagulation potential (vWF) and fibrinolytic 
potential (tPA activity and antigen, and PAI-1).   
  
 
 
 
 
Chapter III 
Methodology 
Research Design 
This study had a cross-sectional design and investigated the predictive value of 
and relationship between physical activity and blood markers for fibrinolytic and blood 
coagulation potential in pregnant women. 
Participants 
Women aged 19-34 years living in the Harrisonburg-Rockingham County area 
and who were currently pregnant.  A total of 23 women enrolled and completed this 
study. 
Recruitment 
Pregnant and postpartum women living in the city of Harrisonburg, Rockingham 
County, and Greater Shenandoah Valley, Virginia, were recruited for this study.  
Investigators met with staff from the Virginia Health Department, the Women Infant 
Children (WIC) program, local OB-GYN clinicians, and other community organizations 
to explain the study and recruit volunteers.  Informational flyers were distributed on-site 
at all locations in both English and Spanish and a bulk email was sent out to all James 
Madison University faculty and staff.  All interested individuals were asked to contact the 
Morrison Bruce Center for the Promotion of Physical Activity for Girls and Women 
(MBC) on the James Madison University campus or sign up at WIC/OB-GYN clinics to 
receive a call from the investigation team.  Informed consent was obtained from every 
participant per the James Madison University Institutional Review Board.  
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Testing Appointment 
Women were asked to complete one testing session, between 6am and 10 a.m. 
following an eight hour fast.  After attaining the informed consent, participants were 
asked to complete a series of questionnaires, measurements, and a venous blood draw.  In 
addition, gestational duration of pregnancy or postpartum were recorded during the 
appointment. All testing appointments were conducted at the Human Performance 
Laboratory at James Madison University.   
Questionnaire or Form Appendix 
 Informed Consent A 
Questionnaire for Blood Draw B 
Supplemental Participant Characteristics C 
Health History  D 
Modifiable Activity  E 
  
Anthropometric Measurements 
 
Height was measured, without shoes, to the nearest 0.5 cm using a stadiometer 
(Seca Weighing and Measuring Systems; Hanover, MD).  Weight was measured, without 
shoes and while wearing light clothing, on a physician type scale to the nearest 0.10 kg 
(Healthometer Inc.; Brideview, IL).  Blood pressure was measured using a blood pressure 
cuff and stethoscope and taken at rest in a seated position (American Diagnostica; 
Stamford, CT).  American College of Sports Medicine standardized procedures for 
obtaining resting blood pressure were followed (Thompson, 2010).  Resting heart rate 
was taken manually palpating the pulse at the radial artery for 60 seconds.    
Venous Blood Draw 
Following an 8-hour fast, participants sat in a semi-recumbent position for 15 
minutes before a blood sample via venapuncture of the antecubital vein was obtained.  
Approximately 9 mL of blood was obtained into one 4.5 mL, 0.11 M sodium citrate 
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collection tube and one 4.5 mL acidified citrate tube.  Samples were immediately spun at 
10,000 rpm for 20 min at 4ºC.  Platelet-poor plasma was stored at -80ºC until assayed.  
tPA antigen and von-Willebrand factor antigen (vWF) were measured using enzyme-
linked immunoabsorbent assays (ELISA), American Diagnostic and Diapharma, 
respectively.  Tissue plasminogen activator inhibitor activity (tPA activity) and 
plasminogen activator inhibitor-1 (PAI-1) were measured using Trinity Biotech bio 
immunoassays.  All values for tPA and PAI-1 were used as markers of fibrinolysis.  Von 
Willebrand factor was used as a marker of blood coagulation.  
Physical Activity Assessment 
The Modifiable Activity Questionnaire (MAQ) was used to recall leisure time 
physical activity over the past 12 months (Kriska, 1990).  Participants selected activities 
that they engage in from a list of 40 common activities and provided information 
regarding frequency (per week), duration (per session) of each activity.  Results were 
used to indirectly determine metabolic equivalent (MET) minutes per week of leisure 
time physical activity (LTPA) by multiplying frequency by duration and estimated METs 
of each activity, determined by the Compendium of Physical Activity (Ainsworth).  
Participants were grouped according to whether they met American College of 
Obstetricians and Gynecologists (ACOG, 2002) and American College of Sports 
Medicine (Haskell, 2007) physical activity recommendations of 450 METmin/wk (or the 
equivalent of completed 150 minutes of moderate physical activity each week) at their 
current state of pregnancy/postpartum (“active”) or not (“sedentary”).   
The MAQ has been widely used in the general population as well as in pregnant 
women (Cramp, 2009; Bauer, 2010) and has shown good validity and reliability in 
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studies using accelerometers and doubly labeled water (Kriska, 1990; Aaron, 1993; 
Aaron, 1995; Schulz, 1994).  Bauer et al. (2010), compared assisted physical activity 
diary data during pregnancy and postpartum in 30 women during pregnancy and 
postpartum with a historical PA recall using the MAQ six years later.  The MAQ showed 
a positive relationship with PAD results at 20 weeks gestation, 32 weeks gestation, and 
12 weeks postpartum (r=0.57, r=0.85, and r=0.86 respectively, all p<0.01).  Bauer’s 
findings are comparable to MAQ validation studies (Kriska, 1990; Aaron, 1993; Aaron, 
1995; Schulz, 1994).   
Average daily step count using a modified placement of Walk (Walk 4 Life) 
pedometers was used as an objective measure of physical activity (Walk, Walk 4 Life 
Inc.).  The pedometers were placed on the right midaxillary line at hip level to avoid 
angling due to a growing fetus and worn for 2 weeks to determine average steps/day.  As 
current literature is inconclusive as to the best placement for pedometers in pregnant 
women (Ling, 2010), placement was determined by piloting various placement positions 
(back, right midaxillary line, pants pocket) in pregnant women. Women kept track of 
their daily step count using a logbook, provided and returned upon convenience of the 
participant.  A total of 19/27 logbooks were returned and used for analysis.  Women were 
categorized as “sedentary” (<5,000 steps/day) or “at least low active” (5,000+ steps/day) 
as an extension of classifications suggested by Tudor-Locke and Bassett in 2004 
(“sedentary = <5,000 steps/day, “low active” = 5,000 – 7,499 steps/day, “somewhat 
active” =7,500 – 9,999 steps/day, and “active” =>10,000 steps/day).     
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Participant Compensation 
For participation in this study, women received two books, an option of either 
keeping the pedometer or a free pack of diapers, and results from their individual blood 
tests.  The books included the fifth edition of the American College of Obstetricians and 
Gynecologists’ “Your Pregnancy and Childbirth: Month to Month” and the La Leche 
League’s “The Breastfeeding Answer Book.”      
Reporting Procedures 
Each participant had access to data pertaining to her individual measurements and 
blood test results at any time.   
Data Analysis 
Descriptive statistics were calculated for all participant variables using 
frequencies, means and standard deviations.  T-tests were used to analyze mean 
differences in blood markers in the 2
nd
 and 3
rd
 trimesters.   
We analyzed physical activity data using the following methods: multiple 
regression, ANCOVA, and linear regression.  Forward stepwise multiple regression 
investigated whether gestational age, average METmin/wk, and average daily step count 
were possible predictive variables for PAI-1, tPA activity, tPA antigen, and vWF.  
ANCOVA analysis was used to determine models to effectively predict PAI-1, tPA 
activity, tPA antigen, and vWF using physical activity groupings (“active” and 
“sedentary” based on 450 METmin/wk recommendation; “at least low active” and 
“sedentary” based on step count classifications of 5,000 steps/day) and gestational age as 
potential predictors.  Scatterplots were used to depict values of our dependent variables 
over gestational age.  From these scatterplots, linear regression equations were used to 
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assess best fit lines among women meeting/not meeting physical activity 
recommendations/guidelines.  Linear regression equations provided information 
regarding y-intercept and slope, allowing us to extrapolate pre-pregnancy levels of the 
dependent variable and analyze mean expected changes in these variables over time.  A p 
value of <0.050 was used to determine statistical significance and a p value of <0.100 
was considered to be approaching statistical significance for all statistical analyses.  
 
 
 
 
 
 
 
Chapter IV 
Manuscript 
Abstract 
Purpose: This study investigated the relationship between blood coagulation and 
fibrinolytic potential and physical activity.  Physical activity levels to predict blood 
coagulation and fibrinolytic potential were also examined.  Methods: Twenty-three 
pregnant women, aged 19-34 yrs, had a fasted blood draw between 6 and 10 a.m. 
analyzed for tPA antigen, tPA activity, PAI-1 antigen, and vWF antigen.  Trimester 
specific volume of leisure time physical activity was assessed by the Modifiable Activity 
Questionnaire (MAQ) and converted to METmin/wk.  Based on MAQ results, women 
were grouped as meeting (“active”) or not meeting (“sedentary”) physical activity 
recommendations established by American College of Obstetrics and Gynecology.  
Average daily step count was calculated from 2 week pedometer logs and women were 
categorized as “sedentary” (<5,000 steps/day) or “at least low active” (5,000+ steps/day) 
according to step count.  Results: PAI-1 and tPA antigen were higher and tPA activity 
was lower during the 3
rd
 trimester of pregnancy versus 2
nd
 trimester.  ANCOVA suggests 
gestational age produced an statistically significant model for predicting PAI-1, tPA 
activity, and tPA antigen, but not vWF; average METmin/wk and step count groupings 
did not produce a statistically significant model predicting PAI-1, tPA antigen, tPA 
activity, or vWF but approached statistical significance for tPA antigen (METmin/wk p = 
0.073 and steps/day p = 0.057).  METmin/wk predicted tPA antigen, during pregnancy, 
in a forward stepwise multiple regression.  Linear regressions based on physical activity 
groups resulted in a significant y-intercept difference (p=0.047) for tPA antigen using 
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step count classifications.  No significant y-intercept or slope differences were seen in 
vWF in relationship to volume of physical activity using a linear regression model. 
Conclusion: It appears this is the first study to explore the relationship between 
hemostasis and volume of physical activity during pregnancy, thus providing an impetus 
for further cross sectional and longitudinal studies in this area.  Future research is needed 
because pregnant women are predisposed to a number of thromboembolic complications 
and other health related issues related to hypercoagulation.  Physical activity may 
enhance fibrinolytic and blood coagulation potential during pregnancy, as it can in non-
pregnant adults. 
Introduction 
The blood coagulation and fibrinolytic cascades involve an intricate series of 
steps and reactions to either enhance the potential to produce fibrin (blood coagulation), 
the key protein in blood clots, or to break down fibrin (fibrinolysis).  Pregnancy is 
defined as a hypercoagulant state, and is characterized by a decrease in fibrinolytic 
activity and an increase in blood coagulation enzymes, resulting in a 2-fold increase in 
coagulation potential in late pregnancy; in healthy women this hypercoagulant state is 
normalized 3-6 weeks postpartum (Choi, 2002; Kruithof, 1987). 
The pattern of increased coagulation potential and reduced fibrinolytic capacity 
during pregnancy may protect pregnant women against the hemostatic challenges of 
placental separation (Bremme, 2003).  However, these changes also present an increased 
risk for thromboembolic complications and hypercoagulability.  The risk for pregnancy 
associated venous thromboembolism (VTE) increases 5.5-6 times compared to 
thromboembolism risk in non-pregnant women of childbearing age (McColl, 1997; 
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Macklon, 1996; McColl, 1999; Ishii, 1994).  Pre-eclampsia, characterized by an altered 
state of hemostasis, is the second leading cause of death during pregnancy and 
predisposes women to an increase in coronary heart disease risk later in life (Walter, 
2000; Sattar, 2002).  The majority of miscarriages are associated with combination with 
coagulation issues and are specifically due to placental vessel thrombosis and infarction 
(Bick, 2000).  Additionally, hemostatic disturbances may lead to poor maternal-fetal 
circulation and ultimately restrict fetal growth (Holmes, 2005; Greer, 2002; Greer, 2003) 
and markers of fibrinolytic inhibition (plasminogen activator inhibitor-1 (PAI-1) and  
tissue-type plasminogen activator (tPA) antigen) have been linked to gestational diabetes 
(Farhan, 2006; Morimitsu, 2007).    
This issue is complicated by the fact that women are becoming pregnant at higher 
starting weights and gaining weight beyond healthy gestational recommendations 
(Huang, 2007; Waller, 2007).  Obesity is known to increase cardiovascular disease risk 
and decrease fibrinolytic potential, increase coagulation potential, and increase 
atherosclerosis (Gaal, 2006) and being overweight/obese is a key risk factor of VTE 
(McColl, 1997; Macklon, 1996; McColl, 1999; Ishii, 1994).  Fat cells synthesize and 
release PAI-1, inhibiting the body’s potential to lyse blood clots.  Obese individuals have 
greater PAI-1, and elevated fibrinogen levels and other coagulation factors versus 
healthy-weighted people (Rauramaa, 1999).  Stewart et al. (2007) reported that obese 
women are in a greater coagulatory state during the first trimester of pregnancy due to 
fibrinolysis inhibition as seen in the PAI-1/PAI-2 ratio.  Although this ratio improved 
among obese women as pregnancy advanced, inability to rebound from this impairment 
could explain elevated maternal risk of pre-eclampsia and hypertension (Stewart, 2007).   
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Participation in regular physical activity (PA) may help an individual reduce 
excess body fat and improve overall body composition (Thompson, 2009; HHS, 1996).  
In addition, regular PA is known to enhance the fibrinolytic profile (Regensteiner, 1995; 
Helmrich, 1991; Dempsey, 2004).  Greater leisure time physical activity (LTPA) and 
endurance training have been shown to decrease PAI-1 and fibrinogen while enhancing 
tPA activity (Eliasson, 1996; Boman, 1994).  
To date, it appears as though there has only been one study investigating the 
relationship between hemostasis and volume of physical activity during pregnancy.  This 
study, by KovalcÃ-kovÃ¡ (1975), is written in Slovak and not available in English, and 
thus little is known about the topic.   
The purpose of the current study was to 1.) study markers of blood coagulation 
and fibrinolysis based on trimester, in pregnant women 2.) determine whether volume of 
physical activity predicts PAI-1, tPA activity, tPA antigen, and vWF in pregnancy and 3.) 
investigate the relationship between volume of physical activity during pregnancy on 
PAI-1, tPA activity, tPA antigen, and vWF.  It was hypothesized that tPA activity would 
be lowest and tPA antigen, PAI-1, and vWF highest in the 3
rd
 trimester and that the extent 
of hypercoagulation during pregnancy would be lower in physically active women, 
versus sedentary women at comparable gestational ages.   
Methods 
Research Design 
This study had a cross-sectional design and investigated the predictive value of and 
relationship between physical activity and blood markers for fibrinolytic and blood 
coagulation potential in pregnancy women. 
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Participants 
Women aged 19-34 years living in the Harrisonburg-Rockingham County area and who 
were currently pregnant were recruited to volunteer for this study.  A total of 23 women 
enrolled and completed this study. 
Testing Appointments 
Women were asked to complete one testing session, between 6am and 10 a.m. 
following an eight hour fast.  After attaining the informed consent, participants were 
asked to complete a series of questionnaires, measurements, and a venous blood draw.  In 
addition, gestational duration of pregnancy or postpartum was recorded during the 
appointment. All testing appointments and measurements were conducted at the Human 
Performance Laboratory at James Madison University.   
Anthropometric Measurements 
 
Height was measured, without shoes, to the nearest 0.5 cm using a stadiometer 
(Seca Weighing and Measuring Systems; Hanover, MD).  Weight was measured, without 
shoes and while wearing light clothing, on a physician type scale to the nearest 0.10 kg 
(Healthometer Inc.; Brideview, IL).  Although pre-pregnancy BMI was calculated using 
self-report weight, current pregnancy BMI was not reported due to a small sample size 
that varied across gestational and postpartum age.  Blood pressure was measured using a 
blood pressure cuff and stethoscope and taken at rest in a seated position (American 
Diagnostica; Stamford, CT).  American College of Sports Medicine standardized 
procedures for obtaining resting blood pressure were followed (Thompson, 2010).  
Resting heart rate was taken manually palpating the pulse at the radial artery for 60 
seconds.    
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Venous Blood Draw 
Following an 8-hour fast, participants sat in a semi-recumbent position for 15 
minutes before a blood sample via venapuncture of the antecubital vein was obtained.  
Approximately 9 mL of blood was obtained into one 4.5 mL, 0.11 M sodium citrate 
collection tube and one 4.5 mL acidified citrate tube.  Samples were immediately spun at 
10,000 rpm for 20 min at 4ºC.  Platelet-poor plasma was stored at -80ºC until assayed.  
tPA antigen and von-Willebrand factor antigen (vWF) were measured using enzyme-
linked immunoabsorbent assays (ELISA) from American Diagnostic and Diapharma, 
respectively.  Tissue plasminogen activator inhibitor activity (tPA activity) and 
plasminogen activator inhibitor-1 (PAI-1) were measured using Trinity Biotech bio 
immunoassays.  All values for tPA and PAI-1 were used as markers of fibrinolysis.  vWF  
was used as markers of thrombosis and blood coagulation.   
Physical Activity Assessment 
The Modifiable Activity Questionnaire (MAQ) was used to recall leisure time 
physical activity over the past 12 months (Kriska, 1990).  Participants selected activities 
that they engage in from a list of 40 common activities and provided information 
regarding frequency (per week), duration (per session) of each activity.  Results were 
used to indirectly determine metabolic equivalent (MET) minutes per week of leisure 
time physical activity (LTPA) by multiplying frequency by duration and estimated METs 
of each activity, determined by the Compendium of Physical Activity (Ainsworth).  
Participants were grouped according to whether they met American College of 
Obstetricians and Gynecologists (ACOG, 2002) and American College of Sports 
Medicine (Haskell, 2007) physical activity recommendations of 450 METmin/wk (or the 
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equivalent of completed 150 minutes of moderate physical activity each week) at their 
current state of pregnancy (“active”) or not (“sedentary”).   
The MAQ has been widely used in the general population as well as in pregnant 
women (Cramp, 2009; Bauer, 2010) and has shown good validity and reliability in 
studies using accelerometers and doubly labeled water (Kriska, 1990; Aaron, 1993; 
Aaron, 1995; Schulz, 1994).  Bauer et al. (2010), compared assisted physical activity 
diary data during pregnancy and postpartum in 30 women during pregnancy and 
postpartum with a historical PA recall using the MAQ six years later.  The MAQ showed 
a positive relationship with PAD results at 20 weeks gestation, 32 weeks gestation, and 
12 weeks postpartum (r=0.57, r=0.85, and r=0.86 respectively, all p<0.01).  Bauer’s 
findings are comparable to MAQ validation studies (Kriska, 1990; Aaron, 1993; Aaron, 
1995; Schulz, 1994).   
Average daily step count using a modified placement of Walk (Walk 4 Life) 
pedometers was used as an objective measure of physical activity (Walk, Walk 4 Life 
Inc.).  The pedometers were placed on the right midaxillary line at hip level to avoid 
angling due to a growing fetus and worn for 2 weeks to determine average steps/day.  As 
current literature is inconclusive as to the best placement for pedometers in pregnant 
women (Ling, 2010), placement was determined by piloting various placement positions 
(back, right midaxillary line, pants pocket) in pregnant women. Women kept track of 
their daily step count using a logbook, provided and returned upon convenience of the 
participant.  A total of 19/23 logbooks were returned and used for analysis.  Women were 
categorized as “sedentary” (<5,000 steps/day) or “at least low active” (5,000+ steps/day) 
as an extension of classifications suggested by Tudor-Locke and Bassett in 2004 
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(“sedentary = <5,000 steps/day, “low active” = 5,000 – 7,499 steps/day, “somewhat 
active” =7,500 – 9,999 steps/day, and “active” =>10,000 steps/day).     
Data Analysis 
Descriptive statistics were calculated for all participant variables using 
frequencies, means and standard deviations.  T-tests were used to analyze mean 
differences in blood markers in the 2
nd
 and 3
rd
 trimesters.   
We analyzed physical activity data using the following methods: multiple 
regression, ANCOVA, and linear regression.  Forward stepwise multiple regression 
investigated whether gestational age, average METmin/wk, and average daily step count 
were possible predictive variables for PAI-1, tPA activity, tPA antigen, and vWF.  
ANCOVA analysis was used to determine models to effectively predict PAI-1, tPA 
activity, tPA antigen, and vWF using physical activity groupings (“active” and 
“sedentary” based on 450 METmin/wk recommendation; “at least low active” and 
“sedentary” based on step count classifications of 5,000 steps/day) and gestational age as 
potential predictors.  Scatterplots were used to depict values of our dependent variables 
over gestational age.  From these scatterplots, linear regression equations were used to 
assess best fit lines among women meeting/not meeting physical activity 
recommendations/guidelines.  Linear regression equations provided information 
regarding y-intercept and slope, allowing us to extrapolate pre-pregnancy levels of the 
dependent variable and analyze mean expected changes in these variables over time.  A p 
value of <0.050 was used to determine statistical significance and a p value of <0.100 
was considered to be approaching statistical significance for all statistical analyses.  
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Results 
Participants 
Twenty-three pregnant women completed this study (mean age 26.09 ± 3.67, 
range 20 – 33 years).  Two women were in the 1
st
 trimester, 12 were in the 2
nd
 semester 
and 9 in the 3
rd
 trimester at the time of their measurement session.  Mean pre-pregnancy 
BMI, assessed using self-reported weight, was 23.54 ± 3.50 kg/m
2 
(range 19.27 – 31.92 
kg/m
2
, n = 21).  Additional participant characteristics can be found in Table 6. 
Table 6. Participant characteristics. 
Characteristic n % 
Number of previous births 
     0 
     1 
     No response 
 
14 
6 
3 
 
60.9 
26.1 
13.0 
Race 
     White (non-Hispanic) 
     Hispanic  
     American Indian/Alaska Native 
     Asian or Pacific Islander 
 
18 
3 
1 
1 
 
78.3 
4.3 
13.0 
4.3 
Marital Status 
     Never married 
     Married or living with partner 
 
3 
20 
 
13.0 
87.0 
Household Income 
     < $20,000 
     $20,000 – $49,000 
     $50,000 – $79,999 
     $80,000+ 
 
7 
3 
7 
6 
 
30.4 
13.0 
30.4 
26.1 
Educational level 
     No high school diploma or GED 
     High school diploma or GED 
     Training beyond high school but no degree 
     Two year associate degree 
     At least one 4-year college degree 
     At least one graduate degree 
 
1 
2 
3 
3 
7 
7 
 
4.3 
8.7 
13.0 
13.0 
30.4 
30.4 
 
Physical Activity 
Prior to pregnancy, 95.7% of women met physical activity recommendations and 
65.2% of women met recommendations during their current trimester of pregnancy.   
Classified by step count (n=19), 53.2% women were considered “sedentary” and 36.8% 
of women “at least low active” during pregnancy.  There was a statistically significant 
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correlation of r = 0.602 (p = 0.006) between average METmin/wk at the current stage of 
pregnancy and average daily step count. 
Fibrinolytic and Blood Coagulation Markers during Pregnancy and Postpartum 
Results for all blood markers were normally distributed.  Independent t-tests were 
run to indicate differences in means between the 2
nd
 and 3
rd
 trimester (Table 7).  Mean 
PAI-1, tPA activity, and tPA antigen showed statistically significant differences between 
2
nd
 and 3
rd
 trimester; PAI-1 and tPA antigen were higher and tPA activity was lower in 
the 3
rd
 trimester versus the 2
nd
 trimester.  No statistical differences were found for vWF, 
though values were higher in 3
rd
 trimester versus 2
nd
 trimester.  Lack of statistical 
significance for vWF may be due to a small sample size which resulted in large standard 
deviations. 
Table 7. Fibrinolytic and blood coagulation variables during the 2
nd
 and 3
rd
 trimester of pregnancy. 
Variable 2
nd
 Trimester 
(n=11)* 
3
rd
 Trimester 
(n=9)
+ 
PAI-1 (IU/mL) 8.41±5.43
 
22.91±5.27
a 
tPA Activity (IU/mL) 0.49±0.26
 
0.20±0.14
a 
tPA Antigen (ng/mL) 2.81±1.50 5.11±1.09
a
 
vWF (%) 124.30±39.37 155.71±46.08 
*n=12 for tPA antigen, 
+
n=7 for PAI-1, 
a
p<0.05 vs 2
nd
 trimester 
 
ANCOVA and multiple regression results suggest that gestational age influence 
PAI-1, tPA activity, and tPA antigen (PAI-1 and tPA antigen are higher and tPA activity 
lower with increased gestational age; Tables 8 and 9).  Gestational age approached 
statistical significance (p = 0.088) as a predictor of vWF in the ANCOVA model using 
physical activity recommendations, but not in the model using step count classifications.  
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Table 8. Significance levels based on ANCOVA analysis of fibrinolytic and blood coagulation variables as 
consequence of time (weeks gestation) and meeting physical activity recommendations/being classified as 
“at least low active” (A = 450 METmin/wk, B = 5,000 steps/day).  All values listed are p values. 
Variable Weeks Gestation 
(A) 
Meeting 
Recommendations 
(A) 
Weeks Gestation 
(B) 
Meeting “At least 
low active” 
Classification (B) 
PAI-1 (IU/mL) <0.001* 0.772 <0.001* 0.175 
tPA Activity (IU/mL) <0.001* 0.607 <0.001* 0.105 
tPA Antigen (ng/mL) 0.006* 0.073^ 0.007* 0.057^ 
vWF (%) 0.088^ 0.948 0.263 0.226 
* = p value <0.050, ^ =p value <0.100 (approaching statistical significance)  
 
Table 9. Multiple regression analysis of fibrinolytic and blood coagulation variables as using weeks 
gestation, average METmin/wk, and average daily step count as possible predictors.  Average METmin/wk 
were calculated using data from each participant’s current trimester. 
Variable Regression equation R
2
 p value 
PAI-1 (IU/mL) -11.285 + 1.040(weeks gestation) 0.844 <0.001 
tPA Activity (IU/mL) 1.195 – 0.032(weeks gestation) 0.569 <0.001 
tPA Antigen (ng/mL)  2.001 + 0.096(weeks gestation) – 0.001(METmin/wk) 0.598 0.001 
vWF (%) No equation based off listed predictors N/A N/A 
 
Volume of Physical Activity and Fibrinolytic and Blood Coagulation Markers  
Meeting physical activity recommendations or being classified as “at least low 
active” did not significantly predict any of the fibrinolytic or blood coagulation variables 
based on ANCOVA results (Table 8).  Additionally, no significant slope differences were 
seen among blood coagulation or fibrinolytic markers in relationship to volume of 
physical activity.  A statistically significant difference in y intercept (p=0.047) was found 
for tPA activity; “at least low active” women had a larger y intercept value versus women 
classified as sedentary.    
Table 10. Differences in slope and y intercept of fibrinolytic and blood coagulation variables during 
pregnancy based on whether women met physical activity recommendations/ were classified as “at least 
low active” (A = 450 METmin/wk, B = 5,000 steps/day). 
 Variable Slope difference 
(A) 
Y intercept 
difference (A) 
Slope difference 
(B) 
Y intercept 
difference (B) 
PAI-1 (IU/mL) 0.026 (p=0.929) 0.029 (p=0.997) 0.206 (p=0.504) 0.575 (p=0.930) 
tPA Activity (IU/mL) 0.013 (p=0.329) 0.392 (p=0.279) 0.033 (p=0.101) 0.871 (p=0.047)* 
tPA Antigen (ng/mL) 0.013 (p=0.871) 1.551 (p=0.469) 0.069 (p=0.523) 0.092 (p=0.967) 
vWF (%) 0.695 (p=0.778) 19.022 (p=0.774) 4.209 (p=0.207) 58.048 (p=0.411) 
* = p value < 0.050 
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Figure 2. Plasminogen Activator Inhibitor-1 (PAI-1) throughout gestation based on volume of current 
physical activity.  Estimation is based on meeting (⁭, dotted line) versus not meeting (○, solid line) 
physical activity recommendations of 450 METmin/wk (A) and step count classifications of 5,000 
steps/day (B).   
   
 
  
Figure 3. Tissue-type Plasminogen Activator activity (tPA activity) throughout gestation based on volume 
of current physical activity.  Estimation is based on meeting (⁭, dotted line) versus not meeting (○, solid 
line) physical activity recommendations of 450 METmin/wk (A) and step count classifications of 5,000 
steps/day (B).   
 
 
 
 
       R2 = 0.815  
       R2 = 0.817  
       R2 = 0.907  
       R2 = 0.655  
 
A B 
       R2 = 0.699 
       R2 = 0.505 
       R2 = 0.701 
       R2 = 0.590 
A B 
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Figure 4. Tissue-type Plasminogen Activator antigen (tPA antigen) throughout gestation based on volume 
of current physical activity.  Estimation is based on meeting (⁭, dotted line) versus not meeting (○, solid 
line) physical activity recommendations of 450 METmin/wk (A) and step count classification of 5,000 
steps/day (B).   
 
 
  
Figure 5. vonWillebrand factor (vWF) throughout gestation based on volume of current physical activity.  
Estimation is based on meeting (⁭, dotted line) versus not meeting (○, solid line) physical activity 
recommendations of 450 METmin/wk (A) and step count classification of 5,000 steps/day (B).   
 
 
 
 
 
 
 
A B 
       R2 = 0.153 
       R2 = 0.145 
       R2 = 0.166 
       R2 = 0.623 
A B 
       R2 = 0.322 
       R2 = 0.350 
       R2 = 0.596 
       R2 = 0.041 
45 
 
 
 
Discussion 
Fibrinolytic Activity 
Trimester-specific Values and Patterns during Pregnancy 
Statistically significantly lower mean values of tPA activity were found in the 3
rd
 
trimester versus the 2
nd
 trimester of pregnancy.  In addition, ANCOVA results suggest 
that gestational age negatively affects tPA activity and multiple regression data shows 
that gestational age is a predictor of tPA activity.  Together, these findings support the 
hypothesis that fibrinolytic activity would be lowest at the end of pregnancy.  Our 
findings are also in agreement with previous longitudinal data showing a reduction in tPA 
activity with each trimester of pregnancy and a normalization towards pre-pregnancy 
values postpartum (Kjellberg, 1999).  This data provides modest support for the idea that 
tPA activity is affected by gestational age and this is most apparent in the late stages of 
pregnancy.   
tPA Activity and Volume of Physical Activity 
Multiple regression analysis and ANCOVA models show that meeting physical 
activity recommendations and being classified as “at least low active” did not have a 
significant effect on predicting tPA activity.  There was a statistically significant 
difference in y intercept in tPA activity after grouping women by step count that was 
similar in pattern but not significant when grouping women by METmin/wk.  In both 
cases, y intercept was greater in the physically active group versus the sedentary group, 
implying that tPA activity is higher pre-pregnancy among physically active individuals.   
Our findings are inconsistent with the hypothesis that tPA activity would be 
enhanced in active pregnant women, versus sedentary pregnant women, at any point 
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during pregnancy.  Research has previously been conducted investigating the relationship 
between physical activity and tPA activity, independent of pregnancy.  Among non-
pregnant women aged 25-64 years, Eliasson et al. (1996) found that tPA activity was 
enhanced due to increased volumes of physical activity.  Our finding that y intercept was 
greater among women meeting physical activity recommendations and classified as “at 
least low active” suggests that women who are active at time of conception have greater 
fibrinolytic potential than their sedentary counterparts.  Though consistent with the idea 
of increased tPA activity due to physical activity (Eliasson, 1996) and the hypothesis that 
active women would start pregnancy with higher tPA activity levels than sedentary 
women, the findings of this study did not determine that physical activity during 
pregnancy affects tPA activity levels.   
 
Fibrinolytic Inhibition 
Trimester-specific values and Patterns during Pregnancy  
Our results indicate that PAI-1 and tPA antigen are were statistically significantly 
for a higher mean 3
rd
 trimester value versus the 2
nd
 trimester mean.  Additionally, 
ANCOVA results suggest that PAI-1 and tPA antigen values are positively affected by 
gestational age and multiple regression found gestational age to be a statistically 
significant predictor of PAI-1 and tPA antigen.  This heightened state of fibrinolytic 
inhibition seen with the advancement of pregnancy is consistent with our hypothesis of 
greatest fibrinolytic inhibition in the 3
rd
 trimester and previous literature suggesting an 
increase in PAI-1 and tPA antigen as pregnancy progresses (Choi, 2002; Cerneca, 1997).   
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Fibrinolytic Inhibition and Volume of Physical Activity 
ANCOVA indicated no statistical significance for meeting physical activity 
recommendations or being classified as “at least low active” predicting tPA antigen or 
PAI-1; however, tPA antigen approached statistical significance under both conditions (p 
= 0.073 and 0.057, respectively).  Further, multiple regression analysis resulted in a 
statistically significant model in which gestational age and average METmin/wk at the 
current trimester of pregnancy predicted tPA antigen.  The multiple regression equation 
suggests that tPA antigen increases by an average of 0.096 ng/mL every week during 
pregnancy but decreases by an average of 0.001 for every additional METmin of physical 
activity.  No statistically significant differences were found in slope or y intercept of tPA 
antigen or PAI-1 when grouped by meeting physical activity recommendations or being 
classified as “at least low active.”    
Previous research has indicated that as level of physical activity increases, 
fibrinolytic inhibition, as observed by tPA antigen and PAI-1 levels, decreases in non-
pregnant adults (Wanamethee, 1996; 2002).  However, in pregnant women, increased 
fibrinolytic inhibition has been indicated as a consequence of increased gestational age, 
independent of volume of physical activity (Choi, 2002; Cerneca, 1997).  Due to these 
conflicting relationships, our hypothesis was that tPA antigen and PAI-1 would be lower 
at the start of pregnancy in active women and the slope of increase would be diminished 
versus sedentary women as pregnancy progressed.  Our multiple regression results 
support the idea that tPA antigen will be higher at greater gestational ages, but that this 
increase in tPA antigen will be diminished by increased activity levels.  This finding is 
novel and suggests that physical activity may attenuate the progression of a 
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hypercoagulant state in pregnancy, which predisposes women to a number of health 
conditions, such as miscarriage, pre-eclampsia, intrauterine growth restriction, venous 
thromboembolism, and diabetes.  The lack of significant findings for PAI-1 is potentially 
due to our small sample size.  Another potential explanation is that majority of women in 
this study entered pregnancy meeting ACOG physical activity recommendations.  
Therefore, the study lacked a true “sedentary” group which would have been beneficial 
during the ANCOVA analysis.  Instead, we possessed a group of women who were active 
pre-pregnancy and decreased activity during pregnancy. 
 
Blood Coagulation 
Trimester-specific Values and Patterns during Pregnancy 
Mean vWF values between 2
nd
 and 3
rd
 trimester were not statistically different 
and multiple regression results found that gestationl age did not predict vWF levels.  
ANCOVA results approached significance (p = 0.088) an effect of gestational age on 
vWF using the physical activity recommendations model but not the step count 
classification model.  Taken as a whole, these findings do not support the hypothesis that 
blood coagulation would be highest in the 3
rd
 trimester or previous studies that have 
established that vWF increases with increasing gestational age (Wickstrom, 2004; Clark, 
1998; Sie, 2003).   Clark et al. (1998) found a non-linear, direct relationship between 
vWF and gestational age in a cross sectional of 239 healthy pregnant women.  If the 
progression of vWF during pregnancy is non-linear, as Clark et al. (1998) suggested, 
having a larger number of participants broken down into smaller ranges of gestation age 
(e.g. 6-12 weeks gestation, 13-19 weeks gestation, etc.) may help in understanding the 
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pattern of blood coagulation, as seen through vWF, during pregnancy.  ANCOVA results 
suggest that a pattern of increased vWF with increasing gestation age may occur, though 
in this study we are likely to have too few participants for this pattern to be evident. 
Blood Coagulation and Volume of Physical Activity 
The ANCOVA indicates that vWF is not predicted by meeting physical activity 
recommendations or being classified as “at least low active.”  Additionally, no statistical 
differences in y intercept or slope were found when the women were grouped.  This 
implies that there was no difference in vWF prior to pregnancy or in estimated vWF 
based on gestational age in “active” and “sedentary” women.  The reader should be 
cautioned that this slope analysis was based off cross-sectional data from a small sample 
size.      
The current findings are in opposition with the hypothesis that women meeting 
physical activity recommendations and being classified as “at least low active” would 
have vWF values that were lower at the start of pregnancy and would have a smaller 
positive slope of increase in comparison their sedentary counterparts.  Previous literature 
has determined an inverse relationship between physical activity and markers of blood 
coagulation, including vWF, independent of pregnancy (Yarnell, 2000; Lakka, 1993; 
Abramson, 2002; Wannameethee, 2002; Panagiotakos, 2005).  However, blood 
coagulation potential is known to increase with the progression of pregnancy 
(Wickstrom, 2004; Clark, 1998; Sie, 2003).  This increase in blood coagulation potential 
is important in late pregnancy, as it may protect pregnant women against the hemostatic 
challenges of placental separation (Bremme, 2003).     
 
50 
 
 
 
Study Limitations and Importance of Future Research 
Our study is limited as a small, cross-sectional study with participants spread 
throughout pregnancy and postpartum and no control data from age-matched, healthy, 
non-pregnant women.  With this design and small study population it is difficult to 
determine if there is a relationship between volume of physical activity, during pregnancy 
and postpartum, on blood coagulation and fibrinolytic potential.   
Another limitation of this study and this area of research is that although normal 
ranges for tPA antigen, tPA activity, PAI-1, vWF, and fibrinogen in women exist, no 
clinical cut points exist for the many markers of fibrinolysis and blood coagulation for 
any population.  A further assessment of these blood markers, beyond a comparison to 
values found in previous studies, is needed as pregnant women are predisposed to health 
related issues related to hypercoagulation including miscarriage, pre-eclampsia, venous 
thromboembolism, intrauterine growth restriction, and diabetes (Greer, 2003). 
Determining cut points for these markers pay provide a considerable advantage to 
clinicians in being able to recognize and possibly treat potential problems related to 
hypercoagulation during pregnancy as well as in the general population.    
In addition to physical activity, BMI has the potential to affect hemostasis in the 
general population and in pregnant women (Stewart, 2007).  It is possible that physical 
activity has an effect on hemostatic variables during pregnancy that we are able to 
address currently.  Findings of this study are limited to the demographics of the 
participants, who had a pre-pregnancy BMI that would be considered healthy and of 
which 95.7% of pregnant women were physically active (exceeding METmin/wk 
physical activity recommendations) pre-pregnancy.  Though multiple regression 
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suggested that volume of physical activity (METmin/wk) helps predict tPA antigen 
during pregnancy, no effect of volume of physical activity during pregnancy on 
hemostatic variables was found in the other blood markers in this group of women who 
were primarily active prior to pregnancy and either maintained or decreased activity 
during pregnancy; this question should be further studied in larger cross-sectional and 
longitudinal studies.  Specifically, the effect of volume of physical activity on fibrinolytic 
and blood coagulation markers in a group of women who are sedentary pre-pregnancy 
and remain inactive, sedentary pre-pregnancy and become active, active pre-pregnancy 
and decrease physical activity, and active pre-pregnancy and remain active through 
pregnancy should be evaluated in concert with pre-pregnancy BMI/body fat levels and 
whether women meet or exceed weight gain recommendations during pregnancy. 
The MAQ has been validated for pregnant women (r=0.57-0.86), and though 
objective data would be preferable over questionnaire data, our objective measure of 
physical activity involved the utilization of a non-validated pedometer placement and 
daily step count information was not received from all participants.  There was though, a 
moderate, significant correlation between MAQ and step count data.  Still, accelerometer 
data (to assess volume of physical activity) may be more telling objective measures of 
physical activity in this population. 
In this study, we classified participants by the volume of physical activity they 
were accruing and then determined whether they were meeting or not meeting physical 
activity recommendations.  Further classifications, such as those proposed by Tudor-
Locke and Bassett in terms of 4 classifications of activity level based on average daily 
step count, may help further answer the question of what level or volume of physical 
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activity creates differences in the progression of hemostatic variables throughout 
pregnancy and postpartum, if differences do exist.  Accelerometer data or fitness 
assessment data (VO2max estimations, etc.) could add important information to help 
further classify level or volume of physical activity during pregnancy and postpartum.   
 
Conclusion    
Other than one study by KovalcÃ-kovÃ¡, published in 1975 (not available in 
English), it appears as though this is this the first study to explore the relationship 
between hemostasis and volume of physical activity in pregnant women.  The finding that 
physical activity (METmin/wk) is predictive of tPA antigen in pregnant women is novel 
and suggests that physical activity may help attenuate the extent of hypercoagulation seen 
in normal pregnancy.  This finding and the current study may help provide an impetus for 
future studies to continue investigating the relationship and predictive values of physical 
activity during pregnancy on markers of fibrinolytic and blood coagulation potential.  
Additional studies are needed as pregnant women are predisposed to a number of 
thromboembolic complications and other health related issues related to hypercoagulation 
including miscarriage, pre-eclampsia, venous thromboembolism, intrauterine growth 
restriction, and diabetes (Greer, 2003).   
 
 
 
 
Chapter V 
Conclusion 
Healthy pregnancy is characterized by increased plasminogen activator inhibitor-1 
(PAI-1), tissue-type plasminogen activator (tPA) antigen, and vonWillebrand factor 
(vWF) and an decreased tPA activity beyond pre-pregnancy levels.  These markers return 
to pre-pregnancy levels after delivery (Choi & Pai, 2002; Holmes, 2005; Hellgren, 2003; 
Bellart et al. 1998; Comeglio et al. 1996). The pattern of increased coagulation potential 
and reduced fibrinolytic capacity during pregnancy may protect pregnant women against 
the hemostatic challenges of placental separation (Bremme, 2003).  However, these 
changes also present an increased risk for thromboembolic complications and 
hypercoagulability.   
Regular physical activity is known to enhance the fibrinolytic profile and reduce 
blood coagulation potential (Regensteiner, 1995; Helmrich, 1991; Dempsey, 2004; 
Womack, 2003; El-Sayed, 2004).  Greater leisure time physical activity (LTPA) and 
endurance training have been shown to decrease PAI-1 while enhancing tPA activity 
(Eliasson, 1996; Boman, 1994). Other than one study by KovalcÃ-kovÃ¡, published in 
1975 and not available in English, it appears as though this is this the first study to 
explore the relationship between hemostasis and volume of LTPA during pregnancy.   
The current study had a cross-sectional design and investigated the relationship 
between blood markers for fibrinolytic and blood coagulation potential and LTPA during 
pregnancy and postpartum.  Twenty three women aged 19-34 living in the Harrisonburg-
Rockingham County area and who were currently pregnant enrolled and completed this 
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study.  Women completed one fasted testing session, between 6am and 10am, in which a 
blood draw was taken for PAI-1, tPA antigen, tPA activity, and vonWillebrand factor.   
The Modifiable Activity Questionnaire (MAQ) was used to recall leisure time 
physical activity over the past 12 months (Kriska, 1990).  Results were used to indirectly 
determine metabolic equivalent (MET) minutes per week of leisure time physical activity 
(LTPA).  Participants were grouped according to whether they met American College of 
Obstetricians and Gynecologists (ACOG, 2002) and American College of Sports 
Medicine (Haskell, 2007) physical activity recommendations of 450 METmin/wk (or the 
equivalent of completed 150 minutes of moderate physical activity each week) at their 
current state of pregnancy (“active”) or not (“sedentary”).  Average METmin/wk for each 
woman’s current state of pregnancy was also used in multiple regression analysis.   
In addition, average daily step count using a modified placement of Walk (Walk 4 
Life) pedometers was used as an objective measure of physical activity (Walk, Walk 4 
Life Inc.).  Women were categorized as “sedentary” (<5,000 steps/day) or “at least low 
active” (5,000+ steps/day) as an extension of classifications suggested by Tudor-Locke 
and Bassett (2004).  Average daily step count was also used in multiple regression 
analysis.   
We found that fibrinolytic inhibition (PAI-1, tPA antigen) was higher and 
fibrinolytic potential (tPA activity) was lower during the 3
rd
 trimester of pregnancy 
versus 2
nd
 trimester.  ANCOVA suggests that while gestational age played a highly 
significant effect on PAI-1, tPA activity, and tPA antigen when analyzed by physical 
activity recommendations and classifications, meeting physical activity recommendations 
did not have a significant effect on predicting any of the fibrinolytic or blood coagulation 
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variables, though tPA antigen approached significance under both physical activity 
conditions.  Significance was found in the multiple regression analysis as volume of 
physical activity (METmin/wk) predicted tPA antigen during pregnancy.  Using a linear 
regression model, no significant y intercept or slope differences were seen in blood 
coagulation in relationship to volume of physical activity.  A significant difference in y 
intercept (p=0.047) was found for tPA antigen; “at least low active” women had a larger 
y intercept than “sedentary” women.    
Our study is limited as a small, cross-sectional study with participants spread 
throughout pregnancy and no control data from age-matched, healthy, non-pregnant 
women.  With this design and numbers, it was difficult to determine the relationship 
between volume of physical activity during pregnancy on blood coagulation and 
fibrinolytic potential.  Regardless, other than one study by KovalcÃ-kovÃ¡, published in 
1975 and not available in English, it appears as though this is this the first study to 
explore the relationship between hemostasis and volume of physical activity during 
pregnancy.  Future research is needed, due to the predisposition of pregnant woman to a 
number of thromboembolic complications and other health related issues related to 
hypercoagulation including miscarriage, pre-eclampsia, venous thromboembolism, 
intrauterine growth restriction, and diabetes (Greer, 2003) and the potential for physical 
activity to enhance fibrinolytic and blood coagulation potential, as it has in non-pregnant 
adults (Eliasson, 1996; Wannamethee, 2002; Womack, 2003; El-Sayed, 2004). 
The effect of volume of physical activity on fibrinolytic and blood coagulation 
markers in a group of women who are sedentary pre-pregnancy and remain inactive, 
sedentary pre-pregnancy and become active, active pre-pregnancy and decrease physical 
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activity, and active pre-pregnancy and remain active through pregnancy should be 
evaluated in concert with BMI or body fat levels.  Additional classifications of physical 
activity level should also be utilized when answering these questions.  Accelerometer 
data or fitness assessment data (VO2max estimations, etc.) could add important information 
to help further classify level or volume of physical activity during pregnancy and 
postpartum.   
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Appendix I 
Consent to Participate in Research 
 
Identification of Investigators & Purpose of Study   
You are being asked to participate in the Fit-Minded Mamas (Madres Saludables) 
research study conducted by Dr. Judith A. Flohr, Kelly Mattran, and Christine 
Nicewonger from James Madison University.  The purpose of this study is to look at how 
volume of physical activity during pregnancy and/or right after child birth changes is 
related to blood sugar and the blood’s ability to form and break down blood clots.  This 
information is important because it helps us provide researchers with information on 
factors that increase or decrease an individual’s risk for diabetes and/or heart disease. 
This study will contribute to the researchers’ completion of their master’s theses. 
 
Research Procedures 
Should you decide to participate in this research study, you will be asked to sign this 
consent form once all your questions have been answered to your approval.  This study 
consists of ONE testing session and the completion of a 2-week pedometer log. The 
testing session involves filling out forms related to physical activity and your feelings 
toward physical activity; measurements including height, weight, hip/waist 
circumferences, and blood pressure; and a blood draw. The blood will be tested for the 
factors/chemicals that help control blood sugar levels and influence your risk for diabetes 
(the chemicals/factors are blood lipids, hemoglobin A1c (HbA1c), fasted insulin, fasted 
glucose) and factors that control how quickly your blood clots (the factors are, tPA 
activity, tPA antigen, PAI-1, von Willebrand factor, and fibrinogen).  The 2-week 
pedometer log is a form where you will record the number of steps you take each day, 
measured by a small device called a pedometer, which will be provided.   
 
Time Required 
Participation in this study will require a total of approximately 90 minutes of your time. 
The test session may take up to an hour of your time.  Filling out the pedometer logs and 
turning them in is intended to take less than 30 minutes (spread out over the two week 
measurement period). We may also contact you, via phone, following this study, to ask 
you questions about your study experience.   
 
Risks  
The investigators do not see more than minimal risks from your involvement in this 
study.  Trained phlebotomists from the JMU Department of Kinesiology and/or JMU 
Health Center will be utilized for all blood draws in which ~3 Tablespoons of blood will 
be taken.  The blood draws are of no greater risk than any other blood draw which would 
normally occur during pregnancy. Safety procedures will be followed during the blood 
draw, including that the researchers will wear non-latex gloves.  After use, sharp objects 
will be placed in a sharps biohazard container and any other biohazard material will go in 
a biohazard bag to be discarded at Rockingham Memorial Hospital.  Following each 
blood draw, the area where your blood draw was taken will be cleaned and bandaged.   
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Benefits 
Potential benefits from participation in this study include obtaining all blood work 
results. In addition, participants will be provided with a pedometer (a device that counts 
the number of steps you take). Participants will also receive pregnancy-related reading 
materials to keep after the 2-week pedometer log is completed and returned to us.     
Confidentiality  
The results of this research will be presented at Masters’ thesis defenses.  The results of 
this project will be coded in such a way that the respondent’s identity will not be attached 
to the final form of this study.  The researcher retains the right to use and publish non-
identifiable data.  While individual responses are confidential, aggregate data will be 
presented representing averages or generalizations about the responses as a whole.  All 
data will be stored in locked file cabinets accessible only to the researchers.  Personal 
information will be stored separately from files with data items, and identification 
numbers will replace participant names on all questionnaires in which signatures are not 
required. Upon completion of the study, all information that matches up individual 
respondents with their answers will be destroyed.  
 
Participation & Withdrawal  
Your participation is entirely voluntary.  You are free to choose not to participate.  
Should you choose to participate, you can withdraw at any time without consequences of 
any kind. 
 
Questions about the Study 
If you have questions or concerns during the time of your participation in this study, or 
after its completion or you would like to receive a copy of the final aggregate results of 
this study, please contact: 
Kelly Mattran   Christine Nicewonger   Dr. Judith A. Flohr 
  
Department of Kinesiology Department of Kinesiology  Department of 
Kinesiology  
James Madison University James Madison University  James Madison 
University 
540-568-4348   540-568-4348    540-568-3448 
mattraka@dukes.jmu.edu nicewocm@ad.jmu.edu  flohrja@ad.jmu.edu  
 
Questions about Your Rights as a Research Subject 
Dr. David Cockley  
Chair, Institutional Review Board 
James Madison University 
(540) 568-2834 
cocklede@jmu.edu 
 
Giving of Consent 
I have read this consent form and I understand what is being requested of me as a 
participant in this study.  I freely consent to participate.  I have been given satisfactory 
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answers to my questions.  The investigator provided me with a copy of this form.  I 
certify that I am at least 18 years of age. 
 
______________________________________     
Name of Participant (Printed) 
 
______________________________________    ______________ 
Name of Participant (Signed)                                   Date 
______________________________________    ______________ 
Name of Researcher (Signed)                                   Date 
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Appendix II 
ID # __________________________ Date _______________________________ 
 
Questionnaire for Blood Draws 
 
 
1. Have you consumed alcoholic beverages within the last 24 hours? ________________ 
 
 
2. Have you used nicotine within the last 10 hours? __________________ 
 
 
3. Have you consumed any food or drink, except water, within the last 10 hours? ______ 
 
 
4. Have you had any infection, fever, or illness within the last week? ________________ 
 
 
5. Have you taken any medication, vitamins, or other nutritional/herbal supplements  
    within the last 12 hours? ______________________________________________ 
 
 
If yes to any question, please explain: 
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Appendix III 
Fit-Minded Mamas: Supplemental Participant Characteristics 
If you are CURRENTLY PREGNANT: 
How far along are you in your current pregnancy? _______wks 
___1st Trimester  ___2nd Trimester ___ 3rd Trimester 
When are you due? __________________(m/d/y) 
 
If you are NOT CURRENTLY PREGNANT (postpartum): 
How old is your most recent child? _______months 
How old were you when you last gave birth? ______yrs 
How much weight did you gain while you were pregnant? _______________lbs 
How much did you weigh before you became pregnant? _____________lbs 
Have you had previous births? ___yes ___no 
a. If yes, how many? _________ 
 
1. What country were you born in?  _________________ 
2. What is your race/ethnicity? (check all that apply) 
___ White (non-Hispanic) 
___ Black (non-Hispanic) 
___ Am Indian/Alaskan Native 
___ Hispanic 
___ Asian or Pacific Islander 
___Other: ___________________ 
3. Which of the following best describes where you live? (Please check one) 
___City of Harrisonburg    
___Rockingham County 
4. Do you feel like there are safe and easily accessible walking routes to and from your house? 
___Yes ___No 
5. Which of the following best describes your current work status? (Please check one) 
___ I am NOT employed outside the home 
___ I am employed part time (less than 35 hours a week) 
___ I am employed fulltime outside the home (35 hours or more a week) 
___ I operate a home based business 
6. Which of the following best describes your average household income? (Please check one) 
___ < $20,000       ___ $20,000-49,999 
___ $50,000-79,999 ___ $80,000+ 
7. Which of the following best describes your highest educational status? (Please check one) 
___ I have NOT received a high school diploma or a GED. 
___ I have a high school degree or a GED 
___ I have a two-year associate degree. 
___ I have education training beyond high school, but I DO NOT have a college 
degree. 
___ I have received at least one, four-year college degree (ie. Bachelors degree) 
___I have received at least one graduate degree (ie. Masters degree, PhD, MD, etc.) 
8. Which of the following best describes your current marital status? (Please check one) 
___ Never married   ___Widowed 
___Divorced/separated   ___ Married or living with partner 
EVERYONE 
ANSWER THESE 
QUESTIONS 
Please fill in ONE 
of these two boxes 
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Appendix IV 
Health History Questionnaire 
 
Instructions: Complete each question accurately. All information provided is 
confidential. 
Part I:  Demographic Information 
 
1.         2.      
 Subject ID  Number      Date 
           
3.           
 Local Phone 
 
4. Email: ____________________________________ 
 
5. Sex (circle one)  Male   Female 
 
6. Date of Birth       
    Month/ Day/ Year 
Part II: Medical History 
 
7. Circle any that died of heart attack before age 50:  Father  Mother  Brother  Sister  
Grandparent  
8. Date of last medical exam: _____________ Last physical fitness test: _________ 
 
9. Circle operations you have had:  Back   Heart   Kidney   Eyes    Joint    Neck     Ears     
Hernia   Lung     Other ________________ 
 
10. Please circle any of the following for which you have been diagnosed of treated by a 
physician or health professional: 
 
Alcoholism   Diabetes   Kidney Problems 
Anemia (sickle cell)  Emphysema   Mental Illness 
Anemia (other)  Epilepsy   Muscular Injury 
Asthma   Eye Problems   Neck Strain 
Back Strain   Gout    Obesity 
Bleeding trait   Hearing Loss   Orthopedic Injuries 
Bronchitis, chronic   Heart Problem   Phlebitis 
Cancer    High Blood Pressure  Rheumatoid arthritis 
Cirrhosis, liver  Hypoglycemia   Stroke 
Concussion   Hyperglycemia  Thyroid problem 
Congenital defect  Infectious Mononucleosis Ulcer 
Other _____________________ 
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11. Circle all medications taken in the last six months: 
 
Blood thinner   Epilepsy medication  Nitroglycerin 
Diabetic pill   Heart-rhythm medication Other __________________ 
Digitalis   High-blood pressure medication 
Diuretic   Insulin 
ID # ______________________ Date ___________________________ 
 
12. Any of these health symptoms that occur frequently is the basis for medical attention. 
Circle the number indicating how often you have each of the following: 
 
5 = Very often    4 = Fairly often   3 = Sometimes   2 = Infrequently   1= Practically never 
 
a. cough up blood   f. chest pain 
    1   2   3   4   5       1   2   3   4   5 
 
b. abdominal pain   g. swollen joints 
    1   2   3   4   5                    1   2   3   4   5 
 
c. low back pain   h. feel faint 
    1   2   3   4   5        1   2   3   4   5 
 
d. leg pain    i. dizziness 
    1   2   3   4   5        1   2   3   4   5 
 
e. arm or shoulder pain  j. breathless on slight exertion 
    1   2   3   4   5         1   2   3   4   5 
 
Part III: Health Related Behavior 
13. Do you smoke?  Yes No 
 
14. If you are a smoker, indicate the number smoked per day: 
 
Cigarettes:  40 or more  20-39  10-19  1-9 
 
Cigars or pipes only:  5 or more or any inhaled less than 5, none inhaled 
 
15. Do you exercise regularly? Yes No 
 
16. How many times in a week do you spend at least 30 minutes in moderate to 
strenuous/vigorous exercise? 
 
 1 2 3 4 5 6 7 days per week 
 
17. Can you walk 4 miles briskly without fatigue? Yes No 
 
18. Can you jog 3 miles continuously at a moderate pace without discomfort?  Yes      No 
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Appendix V 
MODIFIABLE ACTIVITY QUESTIONNAIRE ID# _____________________ Date 
________________ 
1. Please check the box of all activities that you have done more than 10 times in 
the last 12 months from ____________________ to ____________________. 
Activity Month Frequency Duration 
 
JA
N
 
F
E
B
 
M
A
R
 
A
P
R
 
M
A
Y
 
JU
N
 
JU
L
 
A
U
G
 
S
E
P
 
O
C
T
 
N
O
V
 
D
E
C
 Average # 
of times 
per month 
Average # 
of minutes 
each time 
 Aerobic Dance/Step Aerobics               
 Badminton               
 Basketball               
 Bicycling (indoor, outdoor)               
 Bowling               
 Calisthenics/Toning Exercises               
 Canoeing/Rowing/Kayaking               
 Dancing (square, line, ballroom)               
 Elliptical Trainer               
 Fencing               
 Fishing               
 Football/Soccer               
 Gardening or Yardwork               
 Golf               
 Hiking               
 Horseback Riding               
 Hunting               
 Jogging (outdoor, indoor)               
 Jumping Rope               
 Martial Arts (karate, judo)               
 Pilates               
 Racquetball/Handball/Squash               
 Rock Climbing               
 Scuba Diving               
 Skating (roller, ice, blading)               
 Snow Shoeing               
 Snow Skiing (downhill)               
 Snow Skiing (x-country, Nordic   
Track) 
            
  
 Softball/Baseball               
 Stairmaster               
 Strength/Weight Training               
 Swimming (laps, snorkeling)               
 Tai Chi               
 Tennis               
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 Volleyball               
 Walking for Exercise (outdoor, 
indoor, treadmill) 
            
  
 Water Aerobics               
 Yoga               
 Other _____________________               
 
2. Excluding time at work, in general how many HOURS per DAY do you usually spend 
watching television or working on the computer? ________ hours 
 
3. Over this past year, have you spent more than one week confined to a bed or chair as 
a result of an injury, illness, or surgery? Yes _______  No _______ 
 If yes, how many weeks over the past year were you confined to a  
bed or chair? _______ weeks. 
 
4. Do you have difficulty doing any of the following activities? 
 a. getting in or out of a bed or chair?   Yes _______  No _______ 
 b. walking across a small room without resting? Yes _______  No _______ 
c. walking for 10 minutes without resting?  Yes _______  No _______  
  
5. Did you ever compete in an individual or team sport (not including any time spent in 
sports performed during school physical education classes)? Yes _______  No 
_______ 
 If yes, how many total years did you participate in competitive sports? _______ 
years 
 
6. Have you had a job for more than one month over the past year, from last _____ to 
this_____? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
66 
 
 
 
List all JOBS that the individual held over the past 12 months for more than one month.        
Account for all 12 months of the past year.  IF unemployed/disabled/homemaker/student 
during all or part of the past 12 months, list as such and probe for job activities of a 
normal 8 hour day, 5 day week. 
 
 
 
 
 
 
 
 
 
Job 
Name 
 
 
 
 
 
 
 
 
Job 
Code 
 
 
Walk or 
bicycle 
to/from 
work 
 
 
 
Min/Day 
Average Job Schedule 
 Out of the total # of “hrs/day” the individual 
reported working at this “job”, how much of 
this time was usually spent sitting?  Enter 
this # in “hrs sitting” column, then place a 
check in the category that best describes their 
job activities when they are not sitting.  
Hrs. 
spent 
sitting 
at work 
Check the category that 
best describes job 
activities when not sitting 
 
 
 
 
 
Mos/Yr 
 
 
 
 
Days/Wk 
 
 
 
 
Hrs/Day 
 
 
 
Hrs 
Sitting 
 
 
 
 
A 
 
 
 
 
B 
 
 
 
 
C 
          
          
          
          
 
Category A 
(Includes all sitting activities) 
Category B 
(Includes most indoor activities) 
Category C 
(heavy industrial work, outdoor 
construction, farming) 
Sitting Carrying light loads Carrying moderate to heavy loads 
Standing still w/o heavy lifting Continuous walking Heavy construction 
Light cleaning Heavy cleaning Farming 
Driving a bus, taxi, tractor Gardening Digging ditches, shoveling 
Jewelry making/weaving Painting/Plastering Chopping (ax), sawing wood 
General Office Work Plumbing/Welding Tree/pole climbing 
Occasional/short distance 
walking 
 Water/Coal/Wood Hauling 
 
 
JOB CODES 
Not employed outside of the home: Employed (or volunteer): 
1. Student 6. Armed Services 
2. Home Maker 7. Office Worker 
3. Retired 8. Non-Office Worker 
4. Disabled  
5. Unemployed  
 
Kriska, A., Knowler, W., LaPorte, R. (1990). Development of questionnaire to examine 
relationship of physical activity and diabetes in Pima Indians. Diabetes Care, 13: 
401-411. 
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